https://pharmadispatch.com/news/cabinet-document-confirms-limits-on-the-reach-of-pbac-advice 2022-01-17T15:00:01+11:00 https://pharmadispatch.com/news/cynical-hardly-seems-sufficient-to-describe-this-decision 2022-01-05T02:08:01+11:00 https://pharmadispatch.com/news/compare-and-contrast-the-actions-of-two-health-ministers-on-pbs- 2022-01-17T15:00:01+11:00 https://pharmadispatch.com/news/surprise-request-for-tender-before-appointment-of-chair-or-refer 2022-01-09T06:11:01+11:00 https://pharmadispatch.com/news/bpd-conference-2022-still-time-for-early-bird-registration 2022-01-09T07:15:01+11:00 https://pharmadispatch.com/news/a-milestone-that-i-and-many-others-have-been-waiting-for-and-is- 2022-01-09T07:32:01+11:00 https://pharmadispatch.com/news/medicines-australia-confirms-candidates-to-fill-board-vacancies- 2022-01-17T15:00:01+11:00 https://pharmadispatch.com/news/gsk-rejects-unilever-bid-for-consumer-health-business 2022-01-17T15:00:01+11:00 https://pharmadispatch.com/news/industry-acceptance-of-the-status-quo-is-a-barrier-to-achieving- 2022-01-18T15:00:01+11:00 https://pharmadispatch.com/news/cabinet-submission-reveals-brutal-assessment-of-nzs-regulatory-e 2022-01-18T15:00:01+11:00 https://pharmadispatch.com/news/five-years-since-greg-hunts-appointment-to-health-portfolio 2022-01-18T15:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-its-strategic-agreement-steering-committee 2022-01-18T15:00:01+11:00 https://pharmadispatch.com/news/gsk-welcomes-tga-approval-of-parp-inhibitor 2022-01-18T15:00:01+11:00 https://pharmadispatch.com/news/a-legal-review-might-be-more-important-than-the-hta-review 2022-01-19T15:00:01+11:00 https://pharmadispatch.com/news/supply-chain-takes-more-than-half-of-us-brand-medicine-spend 2022-01-19T15:00:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-rebate-extension-for-phone-call-consultatio 2022-01-19T16:56:01+11:00 https://pharmadispatch.com/news/pfizer-laboratory-studies-suggest-covid-19-treatment-effective-a 2022-01-20T15:00:01+11:00 https://pharmadispatch.com/news/ma-hta-review-could-consider-new-non-pbac-pricing-body 2022-01-20T15:00:01+11:00 https://pharmadispatch.com/news/australia-watching-as-uk-reforms-its-decision-making-framework 2022-01-20T15:00:01+11:00 https://pharmadispatch.com/news/is-australian-decision-making-really-based-on-health-technology- 2022-01-21T15:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-vertex-australia-and-new-zealand 2022-01-21T15:00:01+11:00 https://pharmadispatch.com/news/industry-makes-the-list-of-australias-top-employers 2022-01-21T15:00:01+11:00 https://pharmadispatch.com/news/major-milestone-as-tga-announces-approval-of-new-covid-19-option 2022-01-21T15:00:01+11:00 https://pharmadispatch.com/news/release-of-national-medicines-policy-review-submissions-expose-t 2022-01-24T15:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-msd-australia-and-new-zealand 2022-01-24T15:00:01+11:00 https://pharmadispatch.com/news/bayers-ashraf-al-ouf-on-the-need-for-change-a-clear-focus-and-ob 2022-01-24T15:00:01+11:00 https://pharmadispatch.com/news/australians-with-severe-dermatitis-to-benefit-from-pbs-listing 2022-01-24T15:00:01+11:00 https://pharmadispatch.com/news/discussion-on-the-sectors-carbon-footprint-should-least-be-based 2022-01-25T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-joins-the-macquarie-park-innovation-group 2022-01-25T15:00:01+11:00 https://pharmadispatch.com/news/significant-capital-raise-for-emerging-australian-company 2022-01-25T15:00:01+11:00 https://pharmadispatch.com/news/novavax-covid-19-vaccine-to-be-distributed-in-coming-weeks 2022-01-25T15:00:01+11:00 https://pharmadispatch.com/news/the-great-resignation-of-five-ways-to-help-women-thrive 2022-01-27T15:00:01+11:00 https://pharmadispatch.com/news/former-senior-pbs-official-recognised-in-australia-day-honours-l 2022-01-27T15:00:01+11:00 https://pharmadispatch.com/news/bpd-conference-2022-just-days-left-for-early-bird-registration 2022-01-27T15:00:01+11:00 https://pharmadispatch.com/news/nice-adopts-standalone-commitment-to-innovation-and-patient-acce 2022-01-27T15:00:01+11:00 https://pharmadispatch.com/news/companies-initiate-studies-of-omicron-specific-vaccines 2022-01-28T15:00:01+11:00 https://pharmadispatch.com/news/organon-boss-to-deliver-keynote-address-to-women-in-life-science 2022-01-28T15:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-faster-access-to-medicines-vaccines-and-treatments 2022-01-28T15:00:01+11:00 https://pharmadispatch.com/news/three-ma-board-vacancies-become-four-following-a-major-promotion 2022-01-31T15:00:01+11:00 https://pharmadispatch.com/news/over-to-you-minister-it-is-time-to-do-your-job 2022-01-31T15:00:01+11:00 https://pharmadispatch.com/news/more-companies-need-to-start-saying-no-to-bad-outcomes 2022-01-31T15:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-loses-senior-adviser-to-prime-ministers-office 2022-01-31T15:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-welcomes-expanded-listing-for-blood-cancer-therapy 2022-01-31T15:00:01+11:00 https://pharmadispatch.com/news/three-vacancies-turns-to-four-with-major-promotion-for-deputy-ch 2022-01-30T03:14:01+11:00 https://pharmadispatch.com/news/biogen-appoints-new-members-to-its-leadership-team 2022-02-01T15:00:01+11:00 https://pharmadispatch.com/news/new-trial-underway-of-pharmaxis-first-in-class-lox-inhibitor 2022-02-01T15:00:01+11:00 https://pharmadispatch.com/news/guild-calls-for-action-as-medicine-costs-continue-to-rise 2022-02-01T15:00:01+11:00 https://pharmadispatch.com/news/australias-first-reimbursed-thyroid-hrt-not-requiring-refrigerat 2022-02-01T15:00:01+11:00 https://pharmadispatch.com/news/gsk-working-towards-extending-reimbursement-for-respiratory-biol 2022-02-01T15:00:01+11:00 https://pharmadispatch.com/news/should-the-sector-contribute-to-a-political-process-that-seems-n 2022-02-02T15:00:01+11:00 https://pharmadispatch.com/news/medicines-nz-challenges-exclusion-of-pharmac-in-health-system-re 2022-02-02T15:00:01+11:00 https://pharmadispatch.com/news/better-access-australia-calls-for-new-pbs-co-payment-structure 2022-02-02T15:00:01+11:00 https://pharmadispatch.com/news/pm-regrets-delayed-military-supervision-of-vaccine-program 2022-02-02T15:00:01+11:00 https://pharmadispatch.com/news/sector-facing-a-major-change-with-costs-on-track-and-trace 2022-02-03T15:00:01+11:00 https://pharmadispatch.com/news/revised-nmp-adopts-budget-considerations-and-disinvestment 2022-02-02T23:22:01+11:00 https://pharmadispatch.com/news/should-it-be-renamed-the-national-medicines-procurement-policy 2022-02-03T15:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-tells-government-to-try-again-on-revised-nmp 2022-02-03T15:00:01+11:00 https://pharmadispatch.com/news/members-health-welcomes-staged-return-of-elective-surgery-in-nsw 2022-02-03T21:00:01+11:00 https://pharmadispatch.com/news/victorian-research-consortium-to-fight-childhood-cancer 2022-02-03T21:00:01+11:00 https://pharmadispatch.com/news/stlukeshealth-to-pay-benefits-for-rapid-antigen-tests 2022-02-03T21:59:01+11:00 https://pharmadispatch.com/news/action-plan-to-promote-research-industry-commercialisation 2022-02-03T22:02:01+11:00 https://pharmadispatch.com/news/cytiva-announces-winner-of-australia-nz-biochallenge 2022-02-03T22:00:01+11:00 https://pharmadispatch.com/news/planet-innovation-and-lumos-diagnostics-collaborate-on-local-rat 2022-02-03T22:06:01+11:00 https://pharmadispatch.com/news/another-election-at-what-will-be-a-very-important-time-for-the-i 2022-02-04T15:00:01+11:00 https://pharmadispatch.com/news/organon-marks-iwd-with-paid-time-off-to-manage-health-needs 2022-02-04T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-public-affairs-switch-to-az-as-industry-stalwart-steps-ba 2022-02-04T15:00:01+11:00 https://pharmadispatch.com/news/pressure-mounts-to-extend-national-medicines-policy-review 2022-02-04T15:00:01+11:00 https://pharmadispatch.com/news/a-piecemeal-review-that-will-only-entrench-piecemeal-approaches 2022-02-07T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-unites-business-units-under-a-single-brand 2022-02-07T15:00:01+11:00 https://pharmadispatch.com/news/janssen-adds-to-communications-and-public-affairs-team 2022-02-07T15:00:01+11:00 https://pharmadispatch.com/news/it-should-be-about-affordability-for-patients-not-the-government 2022-02-07T00:59:01+11:00 https://pharmadispatch.com/news/labor-slams-the-government-over-national-medicines-policy-review 2022-02-07T15:00:01+11:00 https://pharmadispatch.com/news/new-paper-reveals-shortcomings-in-pbac-consumer-comment-process 2022-02-08T15:00:01+11:00 https://pharmadispatch.com/news/a-portal-to-an-entirely-new-economic-dimension 2022-02-08T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-joins-bca-in-push-to-be-part-of-a-wider-conversation 2022-02-08T15:00:01+11:00 https://pharmadispatch.com/news/extension-possible-but-is-that-enough-for-stakeholders-wanting-c 2022-02-08T15:00:01+11:00 https://pharmadispatch.com/news/bupa-extends-foundation-in-new-zealand-through-new-partnerships 2022-02-08T19:34:01+11:00 https://pharmadispatch.com/news/medibank-encourages-australians-to-prioritise-their-health-check 2022-02-08T19:35:01+11:00 https://pharmadispatch.com/news/clarity-pharmaceuticals-announces-us-based-cobra-study-to-procee 2022-02-08T21:26:01+11:00 https://pharmadispatch.com/news/neuroscientific-biopharmaceuticals-reports-outcomes-of-pre-clini 2022-02-08T21:27:01+11:00 https://pharmadispatch.com/news/medlab-clinical-updates-on-progress-towards-phase-3-trial 2022-02-08T21:28:01+11:00 https://pharmadispatch.com/news/dimerix-appoints-chief-medical-officer 2022-02-08T21:29:01+11:00 https://pharmadispatch.com/news/consultation-extended-but-at-the-cost-of-considering-stakeholder 2022-02-09T15:00:01+11:00 https://pharmadispatch.com/news/nz-patients-once-again-relying-on-charity-for-funded-access 2022-02-09T15:00:01+11:00 https://pharmadispatch.com/news/applications-open-for-industry-backed-bridge-programme 2022-02-09T15:00:01+11:00 https://pharmadispatch.com/news/csl-campaign-challenging-stereotypes-about-people-working-in-sci 2022-02-09T03:46:01+11:00 https://pharmadispatch.com/news/australia-one-of-the-first-developed-countries-to-administer-nov 2022-02-09T15:00:01+11:00 https://pharmadispatch.com/news/independent-mp-calls-for-royal-commission-of-health-sector 2022-02-10T14:00:01+11:00 https://pharmadispatch.com/news/parliamentary-committee-starts-review-of-australia-uk-trade-agre 2022-02-10T14:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-astrazeneca-australia-and-new-zealand 2022-02-09T22:11:01+11:00 https://pharmadispatch.com/news/mark-butler-becomes-a-father-for-the-third-time 2022-02-10T14:00:01+11:00 https://pharmadispatch.com/news/nmp-panel-host-a-scripted-defensive-and-at-times-confused-stakeh 2022-02-10T14:00:01+11:00 https://pharmadispatch.com/news/gbma-welcomes-accord-healthcare-as-a-new-member 2022-02-10T14:00:01+11:00 https://pharmadispatch.com/news/the-national-medicines-policy-review-has-accomplished-what-is-a- 2022-02-11T15:00:01+11:00 https://pharmadispatch.com/news/stakeholders-start-to-unite-against-the-failings-of-nmp-review 2022-02-10T20:57:01+11:00 https://pharmadispatch.com/news/patent-box-legislation-now-before-the-parliament 2022-02-11T15:00:01+11:00 https://pharmadispatch.com/news/biogen-backed-report-highlights-the-coming-impact-of-alzheimers- 2022-02-11T15:00:01+11:00 https://pharmadispatch.com/news/why-stakeholders-are-so-unhappy-with-revised-national-medicines- 2022-02-14T15:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-new-eye-therapy-and-smoking-cessation-review-fi 2022-02-14T15:00:01+11:00 https://pharmadispatch.com/news/move-to-scrap-confidentiality-provisions-set-to-lapse-but-could- 2022-02-14T15:00:01+11:00 https://pharmadispatch.com/news/industry-getting-behind-the-tenth-year-of-fundraising-climb 2022-02-14T15:00:01+11:00 https://pharmadispatch.com/news/enough-is-enough-as-better-access-australia-calls-for-review-to- 2022-02-14T15:00:01+11:00 https://pharmadispatch.com/news/former-ma-chief-executive-claims-victory-in-key-by-election 2022-02-14T15:00:01+11:00 https://pharmadispatch.com/news/exercise-of-discretion-ultimately-a-matter-for-the-next-health-m 2022-02-15T15:00:01+11:00 https://pharmadispatch.com/news/pharmac-consulting-on-widening-access-to-two-off-patent-treatmen 2022-02-15T15:00:01+11:00 https://pharmadispatch.com/news/gbma-announced-the-appointment-of-new-board-director 2022-02-14T22:52:01+11:00 https://pharmadispatch.com/news/consumer-group-backflips-on-co-hosting-roundtable-with-the-indus 2022-02-15T15:00:01+11:00 https://pharmadispatch.com/news/waiting-hoping-and-anticipating-for-an-announcement-on-gene-ther 2022-02-16T15:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-paediatric-indication-for-biologic 2022-02-16T15:00:01+11:00 https://pharmadispatch.com/news/department-of-health-officials-to-front-senate-estimates-today 2022-02-16T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-wins-certification-as-family-friendly-workplace 2022-02-16T15:00:01+11:00 https://pharmadispatch.com/news/a-grab-bag-of-bizarre-theories-amongst-a-smattering-of-sensible- 2022-02-16T15:00:01+11:00 https://pharmadispatch.com/news/there-is-no-nuance-or-subtlety-in-the-fact-patients-come-second- 2022-02-17T15:00:01+11:00 https://pharmadispatch.com/news/csl-working-towards-completing-vifor-acquisition 2022-02-17T02:01:01+11:00 https://pharmadispatch.com/news/bizarre-exchanges-at-senate-estimates-hearing 2022-02-17T15:00:01+11:00 https://pharmadispatch.com/news/call-for-pm-to-intervene-on-nmp-as-one-group-starts-redrafting-p 2022-02-17T15:00:01+11:00 https://pharmadispatch.com/news/the-total-reliance-on-educated-guesswork-is-harming-for-patients 2022-02-18T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-backs-naccho-aboriginal-and-torres-strait-islander-pharma 2022-02-18T02:41:01+11:00 https://pharmadispatch.com/news/there-is-almost-nothing-objective-about-australias-hta-belief-sy 2022-02-21T15:00:01+11:00 https://pharmadispatch.com/news/amgen-scholars-celebrate-a-summer-of-science-in-melbourne 2022-02-21T15:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-immediate-change-in-discount-rate 2022-02-21T15:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-for-chronic-graft-versus-host-disease 2022-02-21T15:00:01+11:00 https://pharmadispatch.com/news/ma-joins-call-for-more-action-on-global-vaccine-equity 2022-02-21T15:00:01+11:00 https://pharmadispatch.com/news/queensland-researcher-secures-gilead-grant-1 2022-02-21T15:00:01+11:00 https://pharmadispatch.com/news/an-opportunity-to-reset-what-has-become-difficult-relationship 2022-02-22T15:00:01+11:00 https://pharmadispatch.com/news/minister-resisting-calls-for-halt-to-national-medicines-policy-r 2022-02-22T15:00:01+11:00 https://pharmadispatch.com/news/starpharma-reports-revenue-growth-and-advances-development 2022-02-22T15:00:01+11:00 https://pharmadispatch.com/news/msd-still-leading-the-way-as-companies-add-more-than-15000 2022-02-22T15:00:01+11:00 https://pharmadispatch.com/news/nib-announces-a-strong-first-half-result-1 2022-02-22T19:58:01+11:00 https://pharmadispatch.com/news/calvary-medibank-using-ai-and-remote-monitoring-to-support-covid 2022-02-22T19:59:01+11:00 https://pharmadispatch.com/news/federal-funding-for-preventive-health-projects-in-victoria 2022-02-22T20:00:01+11:00 https://pharmadispatch.com/news/was-this-vast-and-sprawling-institution-ever-the-intention 2022-02-23T15:00:01+11:00 https://pharmadispatch.com/news/life-saving-medicines-unaffordable-as-pbs-co-pay-heads-to-50-a-s 2022-02-23T15:00:01+11:00 https://pharmadispatch.com/news/ma-holding-firm-on-need-to-push-nmp-review-to-post-election 2022-02-23T15:00:01+11:00 https://pharmadispatch.com/news/bayer-highlights-new-technology-platforms-in-global-briefing 2022-02-23T04:07:01+11:00 https://pharmadispatch.com/news/developed-country-markets-drive-cochlear-growth 2022-02-23T04:39:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-announces-plans-for-a-capital-raise 2022-02-23T04:40:01+11:00 https://pharmadispatch.com/news/arovella-therapeutics-closes-over-subscribed-share-purchase-plan 2022-02-23T04:41:01+11:00 https://pharmadispatch.com/news/csl-behring-joins-british-pharmaceutical-industry-association 2022-02-23T19:51:01+11:00 https://pharmadispatch.com/news/new-study-confirms-the-safety-of-key-covid-19-vaccine 2022-02-24T15:00:01+11:00 https://pharmadispatch.com/news/record-revenue-and-profit-for-australian-company-clinuvel 2022-02-23T21:53:01+11:00 https://pharmadispatch.com/news/chf-makes-the-case-for-access-as-a-basic-need 2022-02-24T15:00:01+11:00 https://pharmadispatch.com/news/government-extends-moderna-vaccine-rollout-to-include-more-child 2022-02-23T23:42:01+11:00 https://pharmadispatch.com/news/australia-and-nz-beaten-by-poland-on-innovative-cystic-fibrosis- 2022-02-24T12:08:01+11:00 https://pharmadispatch.com/news/ama-calls-for-pre-election-focus-on-social-determinants-of-child 2022-02-24T19:23:01+11:00 https://pharmadispatch.com/news/biointelect-boss-on-vaccine-development-and-breaking-down-the-si 2022-03-03T13:00:01+11:00 https://pharmadispatch.com/news/janssen-says-it-cannot-commit-to-supporting-revised-nmp-in-its-c 2022-02-24T20:50:01+11:00 https://pharmadispatch.com/news/have-the-industry-and-other-stakeholders-finally-had-enough 2022-02-25T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-gsk-covid-19-vaccine-excels-in-late-stage-trial 2022-02-25T15:00:01+11:00 https://pharmadispatch.com/news/janssen-gets-backing-as-groups-dig-in-on-nmp-review 2022-02-25T15:00:01+11:00 https://pharmadispatch.com/news/new-portal-offers-online-pathway-for-accessing-cancer-treatments 2022-02-25T15:00:01+11:00 https://pharmadispatch.com/news/kazia-therapeutics-to-be-transformed-by-pipeline-progress 2022-02-25T15:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-indication-for-leading-eye-therapy 2022-02-25T15:00:01+11:00 https://pharmadispatch.com/news/patient-program-suffering-from-political-and-bureaucratic-inacti 2022-02-28T15:00:01+11:00 https://pharmadispatch.com/news/its-official-health-technology-assessment-is-a-joke 2022-02-27T15:00:01+11:00 https://pharmadispatch.com/news/these-patients-are-still-waiting-for-funded-access-to-treatment 2022-02-28T15:00:01+11:00 https://pharmadispatch.com/news/chris-stemple-elevated-to-medicines-australia-deputy-chair 2022-02-28T15:00:01+11:00 https://pharmadispatch.com/news/report-urges-policy-reform-to-ensure-future-access-to-vaccines 2022-02-28T15:00:01+11:00 https://pharmadispatch.com/news/this-is-the-process-all-patients-should-now-expect 2022-02-28T15:00:01+11:00 https://pharmadispatch.com/news/new-pbs-listing-for-australians-with-leukaemia 2022-02-28T15:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-astrazenecas-covid-19-treatment 2022-02-28T01:40:01+11:00 https://pharmadispatch.com/news/pharma-cup-total-approaching-100000-with-less-than-three-weeks-t 2022-03-01T15:00:01+11:00 https://pharmadispatch.com/news/every-australian-patient-has-a-right-to-understand-the-decision- 2022-03-01T15:00:01+11:00 https://pharmadispatch.com/news/alexion-welcomes-new-listing-and-transition-to-pbs 2022-03-01T15:00:01+11:00 https://pharmadispatch.com/news/beigene-hits-a-major-milestone-with-first-medicine-reimbursed-th 2022-03-01T15:00:01+11:00 https://pharmadispatch.com/news/now-the-numbers-are-really-not-adding-up-on-listing-claim 2022-03-03T13:00:01+11:00 https://pharmadispatch.com/news/tavi-now-available-for-more-patients-living-with-severe-aortic-s 2022-03-01T20:53:01+11:00 https://pharmadispatch.com/news/medibank-health-contributes-strong-growth-in-half-year-result 2022-03-01T20:54:01+11:00 https://pharmadispatch.com/news/approval-for-neuren-pharmaceuticals-phase-2-trial-in-angelman-sy 2022-03-01T20:56:01+11:00 https://pharmadispatch.com/news/patrys-select-stable-cell-line-for-the-production-of-pat-dx3 2022-03-01T20:57:01+11:00 https://pharmadispatch.com/news/lucy-turnbull-ao-rejoins-the-board-of-immutep 2022-03-01T20:59:01+11:00 https://pharmadispatch.com/news/orthocell-updates-on-us-market-entry-and-growth 2022-03-01T20:59:01+11:00 https://pharmadispatch.com/news/another-new-zealand-health-insurer-adds-significant-pharmaceutic 2022-03-02T15:00:01+11:00 https://pharmadispatch.com/news/a-big-week-with-stakeholder-consultation-closing-on-major-review 2022-03-02T15:00:01+11:00 https://pharmadispatch.com/news/labor-announces-it-will-fund-expansion-of-patient-pathways-proga 2022-03-02T15:00:01+11:00 https://pharmadispatch.com/news/new-five-year-supply-agreement-between-viatris-and-symbion 2022-03-02T15:00:01+11:00 https://pharmadispatch.com/news/pfizer-welcomes-listing-of-new-blood-cancer-therapy 2022-03-02T15:00:01+11:00 https://pharmadispatch.com/news/quarterly-update-confirms-membership-growth-and-ongoing-impact-o 2022-03-02T23:43:01+11:00 https://pharmadispatch.com/news/insurers-offer-disaster-relief-for-flood-affected-queensland-and 2022-03-02T23:49:01+11:00 https://pharmadispatch.com/news/mental-illness-diet-and-physical-activity-targeted-in-new-heart- 2022-03-02T23:50:01+11:00 https://pharmadispatch.com/news/anteris-technologies-secures-the-backing-of-us-healthcare-invest 2022-03-02T23:56:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics-confirms-atl1102-poster-presentation 2022-03-02T23:57:01+11:00 https://pharmadispatch.com/news/active-agent-in-australian-developed-nasal-spray-highly-active-a 2022-03-02T23:58:01+11:00 https://pharmadispatch.com/news/major-executive-appointments-for-novartis-and-sanofi 2022-03-03T00:23:01+11:00 https://pharmadispatch.com/news/sigma-upgrades-guidance-on-rapid-antigen-test-sales 2022-03-03T14:00:01+11:00 https://pharmadispatch.com/news/sandoz-joins-viatris-in-supply-deal-with-symbion-pharmacy-brands 2022-03-03T01:04:01+11:00 https://pharmadispatch.com/news/we-ended-up-asking-golfers-on-the-seventh-fairway-for-directions 2022-03-03T21:11:01+11:00 https://pharmadispatch.com/news/phrma-price-controls-are-not-the-solution-to-this-problem 2022-03-03T22:22:01+11:00 https://pharmadispatch.com/news/australian-maker-of-green-whistle-jumps-on-fda-decision 2022-03-03T22:49:01+11:00 https://pharmadispatch.com/news/mixed-views-and-experiences-for-the-overweight-or-obese 2022-03-03T23:23:01+11:00 https://pharmadispatch.com/news/evidence-of-something-profoundly-wrong-with-decision-making 2022-03-04T04:05:01+11:00 https://pharmadispatch.com/news/the-bigger-question-for-review-is-whether-this-system-has-actual 2022-03-07T15:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-triggered-pandemic-milestone-with-out-of-pocket-cost 2022-03-07T15:00:01+11:00 https://pharmadispatch.com/news/pharma-cup-total-tops-100000-with-two-weeks-to-go 2022-03-07T15:00:01+11:00 https://pharmadispatch.com/news/tender-documents-raise-questions-over-operationof-review-support 2022-03-07T15:00:01+11:00 https://pharmadispatch.com/news/broad-tga-approval-for-seqirus-cell-based-flu-vaccine 2022-03-08T15:00:01+11:00 https://pharmadispatch.com/news/new-merger-to-form-over-1000-member-pharmacy-alliance 2022-03-08T15:00:01+11:00 https://pharmadispatch.com/news/beigenes-first-australian-employee-marks-international-womens-da 2022-03-08T15:00:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-in-the-list-of-seven-manufacturing-priorities 2022-03-08T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-announces-support-package-for-flood-affected-communities 2022-03-09T15:00:01+11:00 https://pharmadispatch.com/news/government-says-longer-wait-on-price-reduction-impact 2022-03-09T15:00:01+11:00 https://pharmadispatch.com/news/government-warned-rush-will-only-undermine-support-for-national- 2022-03-09T15:00:01+11:00 https://pharmadispatch.com/news/novartis-further-strengthens-gene-therapy-focus-with-new-agreeme 2022-03-09T14:45:01+11:00 https://pharmadispatch.com/news/industry-and-patients-looking-ahead-to-caretaker-conventions 2022-03-10T14:00:01+11:00 https://pharmadispatch.com/news/final-tga-approval-for-breakthrough-cancer-combination 2022-03-10T14:00:01+11:00 https://pharmadispatch.com/news/collaboration-welcomes-new-commitment-to-cepi-moonshot 2022-03-10T14:00:01+11:00 https://pharmadispatch.com/news/a-rebrand-for-australias-largest-life-sciences-venture-fund 2022-03-10T14:00:01+11:00 https://pharmadispatch.com/news/increasing-scrutiny-of-the-industrys-response-to-ukraine 2022-03-11T14:00:01+11:00 https://pharmadispatch.com/news/health-minister-says-pharmac-knows-things-need-to-change 2022-03-11T14:00:01+11:00 https://pharmadispatch.com/news/expanded-approval-for-gsks-shingles-vaccine 2022-03-11T14:00:01+11:00 https://pharmadispatch.com/news/kosi-challenge-fundraising-total-tops-200000-with-one-week-to-go 2022-03-11T14:04:01+11:00 https://pharmadispatch.com/news/sanofi-deliveringvaccine-to-combat-japanese-encephalitis-outbrea 2022-03-14T15:00:01+11:00 https://pharmadispatch.com/news/fundraising-totals-building-fast-with-just-five-days-to-go 2022-03-14T15:00:01+11:00 https://pharmadispatch.com/news/partnership-wants-change-in-how-universities-and-industry-collab 2022-03-14T15:00:01+11:00 https://pharmadispatch.com/news/global-logistics-companies-might-make-the-russia-decision-for-in 2022-03-14T15:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-announces-recipients-of-positive-action-communit 2022-03-15T12:11:01+11:00 https://pharmadispatch.com/news/hunt-and-butler-headline-gbma-budget-week-event 2022-03-15T12:00:01+11:00 https://pharmadispatch.com/news/new-facility-aims-to-enhance-the-delivery-of-cancer-treatment 2022-03-15T12:00:01+11:00 https://pharmadispatch.com/news/seeing-cancer-from-the-other-side-climbing-kosi-in-honour-of-dan 2022-03-15T12:00:01+11:00 https://pharmadispatch.com/news/major-promotion-brings-new-local-leadership-to-sanofi-speciality 2022-03-15T12:00:01+11:00 https://pharmadispatch.com/news/the-bureaucratic-playbook-is-well-and-truly-in-play-with-nmp-rev 2022-03-16T15:00:01+11:00 https://pharmadispatch.com/news/ipsen-australia-recruits-global-support-for-local-rare-cancer-pa 2022-03-16T15:00:01+11:00 https://pharmadispatch.com/news/companies-recognised-by-federal-governments-gender-equality-agen 2022-03-16T15:00:01+11:00 https://pharmadispatch.com/news/industry-starts-to-harden-its-response-to-russias-invasion-of-uk 2022-03-16T15:00:01+11:00 https://pharmadispatch.com/news/htanalysts-launches-new-impact-assessment-consulting-service 2022-03-17T15:00:01+11:00 https://pharmadispatch.com/news/alternative-national-medicines-policy-close-to-finalised 2022-03-17T15:00:01+11:00 https://pharmadispatch.com/news/total-surges-past-300000-with-two-days-to-go 2022-03-17T15:00:01+11:00 https://pharmadispatch.com/news/amgen-foundation-commits-50000-to-support-flood-affected-communi 2022-03-17T15:00:01+11:00 https://pharmadispatch.com/news/an-industry-once-again-suffers-the-consequences-of-a-failed-refo 2022-03-18T15:00:01+11:00 https://pharmadispatch.com/news/ma-confident-concerns-over-nmp-review-are-being-heard 2022-03-18T15:00:01+11:00 https://pharmadispatch.com/news/voluntary-administration-for-contract-sales-force-provider 2022-03-18T15:00:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-support-of-extended-targeted-therapy-cancer 2022-03-18T15:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-budget-focus-on-real-cost-of-living-pre 2022-03-21T15:00:01+11:00 https://pharmadispatch.com/news/new-leadership-forboehringer-ingelheim-australia-and-new-zealand 2022-03-21T15:00:01+11:00 https://pharmadispatch.com/news/clinical-trials-and-new-bureaucracies-will-only-matter-if-they-l 2022-03-21T15:00:01+11:00 https://pharmadispatch.com/news/tenth-annual-kosi-challenge-smashes-fundraising-target 2022-03-21T15:00:01+11:00 https://pharmadispatch.com/news/agreements-have-fundamentally-changed-the-industrys-experience-o 2022-03-22T15:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-the-extent-of-chronic-health-problems 2022-03-22T15:00:01+11:00 https://pharmadispatch.com/news/terrywhite-chemmart-looking-ahead-to-600-pharmacies 2022-03-22T15:00:01+11:00 https://pharmadispatch.com/news/industry-groups-slam-compromise-covid-19-vaccine-patent-waiver 2022-03-22T15:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-welcomes-new-tga-approval-for-zeposia 2022-03-22T15:00:01+11:00 https://pharmadispatch.com/news/pha-why-should-private-patients-pay-more-than-those-in-the-publi 2022-03-22T18:49:01+11:00 https://pharmadispatch.com/news/aged-care-and-health-insurance-drive-bupas-asia-pacific-result 2022-03-22T18:50:01+11:00 https://pharmadispatch.com/news/political-condescension-the-biggest-reform-in-30-years-and-next- 2022-03-23T15:00:01+11:00 https://pharmadispatch.com/news/new-tga-approved-indication-for-seqirus-hay-fever-nasal-spray 2022-03-23T15:00:01+11:00 https://pharmadispatch.com/news/employment-and-procurement-the-focus-of-pfizers-reconciliation-a 2022-03-23T15:00:01+11:00 https://pharmadispatch.com/news/australian-company-progresses-smartphone-covid-test 2022-03-23T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-delivers-high-dose-four-strain-flu-vaccine-for-over-60s 2022-03-30T15:00:01+11:00 https://pharmadispatch.com/news/medadvisor-says-digital-prescription-management-to-keep-seniors- 2022-03-24T15:00:01+11:00 https://pharmadispatch.com/news/more-pharmaceutical-companies-refining-their-response-to-russia 2022-03-24T15:00:01+11:00 https://pharmadispatch.com/news/one-year-and-over-1000-deaths-since-the-launch-of-odtp-post-mark 2022-03-25T15:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-appoints-leader-of-new-rare-disease-unit 2022-03-24T15:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-succumbs-to-inevitable-on-national-medicines-policy-re 2022-03-24T15:00:01+11:00 https://pharmadispatch.com/news/this-obvious-gaslighting-of-stakeholders-needs-to-stop 2022-03-25T15:00:01+11:00 https://pharmadispatch.com/news/ma-and-ausbiotech-join-global-criticism-of-covid-ip-waiver-compr 2022-03-25T15:00:01+11:00 https://pharmadispatch.com/news/beigene-appoints-new-head-of-haematology-for-australia-and-nz 2022-03-25T15:00:01+11:00 https://pharmadispatch.com/news/federal-government-grant-to-expand-viatris-production-in-austral 2022-03-25T15:00:01+11:00 https://pharmadispatch.com/news/organon-employees-making-first-use-of-support-service 2022-03-25T15:00:01+11:00 https://pharmadispatch.com/news/victoria-the-first-jurisdiction-to-fund-gene-therapy 2022-03-25T18:47:01+11:00 https://pharmadispatch.com/news/it-is-a-great-outcome-but-we-have-a-right-to-know-what-happened 2022-03-27T17:00:01+11:00 https://pharmadispatch.com/news/price-limits-price-cuts-and-price-policies-the-focus-of-latest-l 2022-03-28T15:00:01+11:00 https://pharmadispatch.com/news/call-for-clear-commitments-on-new-national-medicines-policy-revi 2022-03-28T15:00:01+11:00 https://pharmadispatch.com/news/retiring-minister-delivers-not-so-subtle-swipe-at-bureaucracy 2022-03-28T15:00:01+11:00 https://pharmadispatch.com/news/organisations-setting-our-their-asks-for-2022-23-budget 2022-03-28T15:00:01+11:00 https://pharmadispatch.com/news/former-industry-minister-announces-retirement-from-politics 2022-03-28T15:00:01+11:00 https://pharmadispatch.com/news/nz-patients-call-on-the-government-to-stop-with-its-hypocrisy 2022-03-29T15:00:01+11:00 https://pharmadispatch.com/news/the-industry-is-not-expecting-any-surprises-in-tonights-budget 2022-03-29T15:00:01+11:00 https://pharmadispatch.com/news/evolving-technologies-challenge-existing-funding-pathways 2022-03-29T15:00:01+11:00 https://pharmadispatch.com/news/did-the-company-accept-the-terms-or-was-it-the-other-way-around 2022-03-29T15:00:01+11:00 https://pharmadispatch.com/news/pfizer-launches-new-self-injecting-device-with-smartphone-app 2022-03-29T15:00:01+11:00 https://pharmadispatch.com/news/access-to-treatment-should-be-considered-a-fundamental-human-rig 2022-03-31T15:00:01+11:00 https://pharmadispatch.com/news/sigma-healthcare-reports-a-year-of-contrasting-halves 2022-03-30T15:00:01+11:00 https://pharmadispatch.com/news/the-pbs-shows-declining-spend-as-it-now-almost-always-will 2022-03-30T06:00:01+11:00 https://pharmadispatch.com/news/microbio-announces-capital-raise-to-support-product-launch 2022-03-30T04:09:01+11:00 https://pharmadispatch.com/news/neuren-receives-fda-approval-for-pitt-hopkins-ind-and-phase-2-tr 2022-03-30T04:09:01+11:00 https://pharmadispatch.com/news/hexima-presents-data-on-new-topical-treatment 2022-03-30T04:11:01+11:00 https://pharmadispatch.com/news/dimerix-receives-rd-tax-rebate-for-last-financial-year 2022-03-30T04:12:01+11:00 https://pharmadispatch.com/news/teachers-health-group-extends-extras-cover 2022-03-30T04:13:01+11:00 https://pharmadispatch.com/news/medibank-implements-fifth-reconciliation-action-plan 2022-03-30T04:14:01+11:00 https://pharmadispatch.com/news/avecho-reports-positive-results-for-phase-2-topical-cbd-osteoart 2022-03-30T04:21:01+11:00 https://pharmadispatch.com/news/a-declining-forecast-is-a-natural-consequence-of-the-sectors-agr 2022-03-30T15:00:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-new-listing-but-urges-action-on-newborn-screen 2022-03-30T15:00:01+11:00 https://pharmadispatch.com/news/budget-2022-23-the-stakeholder-response 2022-03-30T08:04:01+11:00 https://pharmadispatch.com/news/budget-2022-23-and-the-lowering-of-expectations 2022-03-30T09:28:01+11:00 https://pharmadispatch.com/news/budget-disappointment-for-diabetes-patients 2022-03-31T15:00:01+11:00 https://pharmadispatch.com/news/rare-disease-and-new-migraine-biologic-for-july-pbac 2022-03-31T15:00:01+11:00 https://pharmadispatch.com/news/budget-delivers-major-blow-for-nps-medicinewise-with-loss-of-qum 2022-03-31T15:00:01+11:00 https://pharmadispatch.com/news/an-outcome-that-was-almost-certainly-ten-years-in-the-making 2022-04-01T15:00:01+11:00 https://pharmadispatch.com/news/patient-group-welcomes-report-of-parliamentary-inquiry 2022-04-01T15:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-gsks-triple-combination-for-severe-asthma 2022-04-01T15:00:01+11:00 https://pharmadispatch.com/news/strong-community-support-for-national-action-on-newborn-screenin 2022-04-01T15:00:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-viiv-healthcares-long-acting-hiv-treatment 2022-04-01T15:00:01+11:00 https://pharmadispatch.com/news/ministers-claim-was-not-really-an-accurate-representation-of-the 2022-04-04T14:00:01+10:00 https://pharmadispatch.com/news/the-company-stood-its-ground-with-final-offer-on-key-therapy 2022-04-04T14:00:01+10:00 https://pharmadispatch.com/news/post-election-pricing-anticipation-of-medicine-sponsors 2022-04-04T14:00:01+10:00 https://pharmadispatch.com/news/australian-healthcare-investor-urges-greater-support-from-peers 2022-04-04T02:47:01+10:00 https://pharmadispatch.com/news/if-it-can-happen-to-them-it-can-happen-to-anyone 2022-04-05T14:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-planning-largest-support-infrastructure-for- 2022-04-06T14:00:01+10:00 https://pharmadispatch.com/news/msds-pbs-listed-covid-19-treatment-delivers-in-late-stage-trial 2022-04-05T14:00:01+10:00 https://pharmadispatch.com/news/brands-will-be-automatically-designated-for-minimum-stockholding 2022-04-05T14:00:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-makes-first-statement-since-budget-defunding 2022-04-05T14:48:01+10:00 https://pharmadispatch.com/news/novartis-announces-a-major-organisational-restructure 2022-04-05T14:00:01+10:00 https://pharmadispatch.com/news/apha-announces-the-recipients-of-2022-awards-for-excellence 2022-04-05T18:34:01+10:00 https://pharmadispatch.com/news/medibank-launches-pilot-to-combat-malnutrition-in-seniors 2022-04-05T18:35:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-publication-of-rd-tax-incentive-determinatio 2022-04-06T14:00:01+10:00 https://pharmadispatch.com/news/microba-announces-new-research-partnership-and-senior-appointmen 2022-04-05T21:39:01+10:00 https://pharmadispatch.com/news/telix-pharmaceuticals-confirms-us-commercial-launch-of-illuccix 2022-04-05T21:40:01+10:00 https://pharmadispatch.com/news/bio-gene-signs-agreement-on-flavocide-technology 2022-04-05T21:41:01+10:00 https://pharmadispatch.com/news/industry-hopeful-ofpre-election-confirmation-of-hta-reference-co 2022-04-06T14:00:01+10:00 https://pharmadispatch.com/news/could-2023-be-the-biggest-delisting-year-in-pbs-history 2022-04-06T14:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-delivers-solid-performance-in-australia 2022-04-06T14:00:01+10:00 https://pharmadispatch.com/news/labor-announces-dramatic-expansion-of-newborn-screening 2022-04-06T18:16:01+10:00 https://pharmadispatch.com/news/the-real-surprise-is-that-this-national-takeover-is-actual-refor 2022-04-07T14:00:01+10:00 https://pharmadispatch.com/news/demand-for-flu-vaccinations-expected-to-soar-ahead-of-winter 2022-04-06T20:21:01+10:00 https://pharmadispatch.com/news/bupa-cautions-against-do-it-yourself-dentistry 2022-04-06T20:28:01+10:00 https://pharmadispatch.com/news/rush-to-welcome-commitment-to-end-the-lottery-that-is-screening- 2022-04-07T14:00:01+10:00 https://pharmadispatch.com/news/minister-your-response-only-confirms-the-need-for-this-reform 2022-04-06T23:19:01+10:00 https://pharmadispatch.com/news/gsk-consumer-healthcare-in-cbd-agreement-with-australian-company 2022-04-07T14:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-announces-support-for-major-new-resilience-projects 2022-04-07T14:00:01+10:00 https://pharmadispatch.com/news/edit-a-thon-returns-to-elevate-online-recognition-of-women-in-st 2022-04-07T14:00:01+10:00 https://pharmadispatch.com/news/agilex-biolabs-appoints-a-new-chief-scientific-officer 2022-04-07T18:47:01+10:00 https://pharmadispatch.com/news/inoviq-and-university-of-queensland-expand-collaboration 2022-04-07T18:48:01+10:00 https://pharmadispatch.com/news/race-receives-human-ethics-approval-for-new-trial 2022-04-07T18:49:01+10:00 https://pharmadispatch.com/news/government-funded-report-raises-alarm-over-vaping 2022-04-08T14:00:01+10:00 https://pharmadispatch.com/news/newborn-screening-the-how-the-what-and-the-why 2022-04-08T14:00:01+10:00 https://pharmadispatch.com/news/senate-inquiry-delivers-damning-assessment-of-vaccine-plan 2022-04-08T14:00:01+10:00 https://pharmadispatch.com/news/department-of-health-the-responsible-person-for-pfizers-covid-tr 2022-04-11T14:00:01+10:00 https://pharmadispatch.com/news/an-appointment-that-is-a-parting-and-very-revealing-gift-to-pati 2022-04-11T14:00:01+10:00 https://pharmadispatch.com/news/it-is-hard-to-imagine-a-worst-appointment-to-lead-hta-review 2022-04-10T20:29:01+10:00 https://pharmadispatch.com/news/stakeholders-must-not-accept-this-generational-threat-to-access 2022-04-11T14:00:01+10:00 https://pharmadispatch.com/news/morrison-to-reveal-health-minister-pick-in-the-next-week-or-so 2022-04-11T00:08:01+10:00 https://pharmadispatch.com/news/the-industry-needs-to-quickly-get-match-fit-for-this-fight 2022-04-12T14:00:01+10:00 https://pharmadispatch.com/news/pfizer-announces-acquisition-of-australian-digital-health-compan 2022-04-11T21:50:01+10:00 https://pharmadispatch.com/news/labor-says-no-to-greg-hunts-hta-review-reference-committee 2022-04-12T14:00:01+10:00 https://pharmadispatch.com/news/announcement-of-hta-review-reference-committee-designed-to-beat- 2022-04-13T14:00:01+10:00 https://pharmadispatch.com/news/youth-mental-health-is-the-silent-pandemic 2022-04-12T20:56:01+10:00 https://pharmadispatch.com/news/the-unabashed-rationalist-says-in-many-respects-i-am-different 2022-04-12T23:10:01+10:00 https://pharmadispatch.com/news/the-government-should-consider-withdrawing-from-medicine-provisi 2022-04-13T14:00:01+10:00 https://pharmadispatch.com/news/further-work-halted-as-caretaker-conventions-kick-in 2022-04-13T14:00:01+10:00 https://pharmadispatch.com/news/election-buys-more-time-on-controversial-confidentiality-move 2022-04-14T14:00:01+10:00 https://pharmadispatch.com/news/pfizers-anne-harris-on-authentically-working-towards-reconciliat 2022-04-14T14:00:01+10:00 https://pharmadispatch.com/news/this-appointment-will-mean-stakeholders-need-to-block-this-revie 2022-04-19T14:00:01+10:00 https://pharmadispatch.com/news/naccho-announces-recipients-of-sanofi-supported-scholarships 2022-04-14T14:00:01+10:00 https://pharmadispatch.com/news/prime-minister-confirms-south-australian-senator-for-health-port 2022-04-17T18:41:01+10:00 https://pharmadispatch.com/news/vertex-conclusions-based-on-a-flawed-analysis-of-available-data 2022-04-18T19:47:01+10:00 https://pharmadispatch.com/news/second-week-of-election-campaign-starts-with-pbs-and-diabetes-co 2022-04-19T14:00:01+10:00 https://pharmadispatch.com/news/agenda-building-for-biopharmadispatch-conference 2022-04-19T14:00:01+10:00 https://pharmadispatch.com/news/a-health-minister-in-the-senate-will-make-a-huge-difference 2022-04-19T14:00:01+10:00 https://pharmadispatch.com/news/nib-launches-new-health-insurance-partnership-with-priceline-pha 2022-04-19T19:10:01+10:00 https://pharmadispatch.com/news/uq-microbiopsy-deal-could-change-the-way-skin-conditions-are-dia 2022-04-19T19:11:01+10:00 https://pharmadispatch.com/news/epiaxis-therapeutics-appoints-new-chief-science-officer 2022-04-19T19:12:01+10:00 https://pharmadispatch.com/news/zelira-therapeutics-executes-acquisition-of-health-house 2022-04-19T19:13:01+10:00 https://pharmadispatch.com/news/uk-adopts-new-evaluation-framework-for-subscription-antibiotics 2022-04-20T14:00:01+10:00 https://pharmadispatch.com/news/the-next-minister-could-fundamentally-alter-these-reviews 2022-04-20T14:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-backs-research-australias-pre-election-call-for-actio 2022-04-20T14:00:01+10:00 https://pharmadispatch.com/news/pbac-is-elevated-in-law-but-also-significantly-constrained 2022-04-21T14:00:01+10:00 https://pharmadispatch.com/news/pharmacies-part-of-private-equity-takeover-of-ramsay 2022-04-21T12:00:01+10:00 https://pharmadispatch.com/news/pre-election-outlook-provides-confusing-picture-on-new-medicines 2022-04-21T14:00:01+10:00 https://pharmadispatch.com/news/if-this-committee-is-to-have-a-policy-role-the-law-needs-to-chan 2022-04-22T14:00:01+10:00 https://pharmadispatch.com/news/csl-progresses-vifor-acquisition-with-successful-bond-issue 2022-04-22T14:00:01+10:00 https://pharmadispatch.com/news/arovella-therapeutics-announces-manufacturing-agreement-with-q-g 2022-04-21T23:20:01+10:00 https://pharmadispatch.com/news/kazia-therapeutics-says-phase-2-study-of-paxalisib-completed 2022-04-21T23:21:01+10:00 https://pharmadispatch.com/news/medlab-clinical-confirms-northern-hemisphere-distribution 2022-04-21T23:21:01+10:00 https://pharmadispatch.com/news/volpara-health-announces-leadership-and-board-changes 2022-04-21T23:22:01+10:00 https://pharmadispatch.com/news/bupa-calls-for-reform-to-keep-health-system-out-of-intensive-car 2022-04-21T23:23:01+10:00 https://pharmadispatch.com/news/call-to-fund-insulin-pump-that-has-been-recommended-and-promised 2022-04-21T23:24:01+10:00 https://pharmadispatch.com/news/expansion-widely-welcomed-but-implementation-timeline-a-challeng 2022-04-22T00:00:01+10:00 https://pharmadispatch.com/news/medicinal-cannabis-setting-new-all-time-highs 2022-04-22T14:00:01+10:00 https://pharmadispatch.com/news/viatris-leaders-say-the-focus-is-on-sustainability 2022-04-24T21:48:01+10:00 https://pharmadispatch.com/news/a-custodian-working-towards-giving-an-unambiguous-no 2022-04-26T14:00:01+10:00 https://pharmadispatch.com/news/gilead-welcomes-pbs-listing-of-new-breast-cancer-therapy 2022-04-26T14:00:01+10:00 https://pharmadispatch.com/news/hope-for-more-sufferers-of-migraine-but-more-work-on-weight-los 2022-04-26T14:00:01+10:00 https://pharmadispatch.com/news/nib-launches-greenpass-health-membership 2022-04-26T18:03:01+10:00 https://pharmadispatch.com/news/hesta-part-of-consortium-bidding-for-ramsay-health-care 2022-04-26T18:04:01+10:00 https://pharmadispatch.com/news/release-of-first-standard-for-use-of-opioids-in-acute-care 2022-04-26T18:05:01+10:00 https://pharmadispatch.com/news/mtpconnect-announces-the-appointment-of-new-leadership 2022-04-27T14:00:01+10:00 https://pharmadispatch.com/news/sanofi-grants-to-support-community-based-vaccine-education 2022-04-27T14:00:01+10:00 https://pharmadispatch.com/news/will-the-review-fix-the-use-of-pricing-policy-in-pbac-outcomes 2022-04-27T14:00:01+10:00 https://pharmadispatch.com/news/biogens-kylie-bromley-promoted-to-uk-managing-director 2022-04-27T14:00:01+10:00 https://pharmadispatch.com/news/msd-looks-forward-to-reimbursement-after-recommendations 2022-04-28T14:00:01+10:00 https://pharmadispatch.com/news/csl-and-aspen-medical-names-as-two-of-the-best-places-to-work 2022-04-28T14:00:01+10:00 https://pharmadispatch.com/news/gsk-boosts-parental-leave-across-australia-and-new-zealand-opera 2022-04-28T14:00:01+10:00 https://pharmadispatch.com/news/spike-in-inflation-points-to-dramatic-jump-in-pbs-co-payments 2022-04-28T14:00:01+10:00 https://pharmadispatch.com/news/apha-welcomes-focus-on-health-workforce-but-wants-to-see-the-pol 2022-04-28T19:27:01+10:00 https://pharmadispatch.com/news/bupa-warns-agains-vaccination-fatigue-as-flu-season-approaches 2022-04-28T19:30:01+10:00 https://pharmadispatch.com/news/cochlear-agrees-to-acquire-oticon-medical 2022-04-28T19:31:01+10:00 https://pharmadispatch.com/news/labor-promises-audit-of-government-spending-and-a-new-budget 2022-04-29T14:00:01+10:00 https://pharmadispatch.com/news/a-point-of-difference-that-is-already-having-implications 2022-04-29T14:00:01+10:00 https://pharmadispatch.com/news/reports-shame-list-identifies-access-gaps-for-new-zealands-cance 2022-04-29T14:00:01+10:00 https://pharmadispatch.com/news/janssen-and-illumina-team-up-on-precision-medicine-development 2022-04-29T14:00:01+10:00 https://pharmadispatch.com/news/coalition-commits-to-cut-con-concessional-pbs-co-payment 2022-04-30T16:00:01+10:00 https://pharmadispatch.com/news/part-of-being-a-custodian-is-saving-decision-makers-from-their-o 2022-05-01T14:00:01+10:00 https://pharmadispatch.com/news/everything-happens-for-a-reason-including-words-and-appointments 2022-05-05T14:00:01+10:00 https://pharmadispatch.com/news/labor-trumps-coalition-with-plan-to-cut-pbs-co-pay-to-30-1 2022-05-02T14:00:01+10:00 https://pharmadispatch.com/news/long-acting-treatment-for-pbs-but-is-it-affordable-for-patients 2022-05-02T14:00:01+10:00 https://pharmadispatch.com/news/part-of-being-a-custodian-is-saving-decision-makers-from-their-o 2022-05-01T14:00:01+10:00 https://pharmadispatch.com/news/investment-in-australian-collaboration-targeting-inflammatory-lu 2022-05-03T14:00:01+10:00 https://pharmadispatch.com/news/dr-brendan-shaw-co-payment-cuts-signal-the-end-of-pbs-fiscal-aus 2022-05-02T22:11:01+10:00 https://pharmadispatch.com/news/setting-a-new-benchmark-for-parental-leave-polices 2022-05-03T14:00:01+10:00 https://pharmadispatch.com/news/great-place-to-work-accreditation-for-beigene-australia 2022-05-04T14:00:01+10:00 https://pharmadispatch.com/news/award-winners-recognised-in-pharmaceutical-industry-education 2022-05-04T14:00:01+10:00 https://pharmadispatch.com/news/the-change-coming-for-australians-living-with-diabetes 2022-05-04T14:00:01+10:00 https://pharmadispatch.com/news/dr-falk-and-clinicians-welcomes-reimbursement-of-new-treatment-1 2022-05-04T14:00:01+10:00 https://pharmadispatch.com/news/new-ceo-for-australian-unity-private-health-insurance-business 2022-05-04T18:06:01+10:00 https://pharmadispatch.com/news/hcf-backs-sport-and-wellness-start-up 2022-05-04T18:07:01+10:00 https://pharmadispatch.com/news/labor-commits-to-review-nps-medicinewise-defunding-decision 2022-05-05T14:00:01+10:00 https://pharmadispatch.com/news/next-minister-confronted-by-unfinished-reviews-processes-and-out 2022-05-05T14:00:01+10:00 https://pharmadispatch.com/news/ramsay-health 2022-05-05T03:29:01+10:00 https://pharmadispatch.com/news/members-health-calls-for-restoration-of-private-health-insurance 2022-05-05T18:36:01+10:00 https://pharmadispatch.com/news/rt-health-helping-families-cover-their-kids-for-longer 2022-05-05T18:38:01+10:00 https://pharmadispatch.com/news/carbon-free-me-backing-bpd-conference-to-manage-and-offset-emiss 2022-05-06T14:00:01+10:00 https://pharmadispatch.com/news/gileads-jaime-mccoy-says-the-priority-must-be-a-proper-strategic 2022-05-06T14:00:01+10:00 https://pharmadispatch.com/news/takedas-brad-edwards-promoted-to-senior-regional-role 2022-05-06T14:00:01+10:00 https://pharmadispatch.com/news/novartis-confirms-leadership-of-local-integration 2022-05-06T22:06:01+10:00 https://pharmadispatch.com/news/ma-says-no-to-proposed-chair-of-hta-review-reference-committee 2022-05-09T14:00:01+10:00 https://pharmadispatch.com/news/welcome-outcome-an-opportunity-to-get-real-about-the-realities-o 2022-05-09T14:00:01+10:00 https://pharmadispatch.com/news/national-recognition-for-the-head-of-bms-legal-team 2022-05-08T22:07:01+10:00 https://pharmadispatch.com/news/labor-calls-on-coalition-to-match-its-commitment-to-expand-newbo 2022-05-10T14:00:01+10:00 https://pharmadispatch.com/news/we-need-to-know-the-why-before-worrying-about-the-how 2022-05-10T14:00:01+10:00 https://pharmadispatch.com/news/tga-approves-earlier-access-to-gileads-covid-19-antiviral-treatm 2022-05-10T14:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-wins-federal-government-manufacturing-support 2022-05-10T14:00:01+10:00 https://pharmadispatch.com/news/tests-a-critical-step-to-treatment-for-vision-loss 2022-05-10T20:37:01+10:00 https://pharmadispatch.com/news/us-fda-ind-approval-for-dimerix-late-stage-study 2022-05-10T20:38:01+10:00 https://pharmadispatch.com/news/imugene-secures-australian-ethics-approval-for-her-vaxx-trial 2022-05-10T20:39:01+10:00 https://pharmadispatch.com/news/prescient-expands-ptx-200-aml-cohort-following-additional-comple 2022-05-10T20:40:01+10:00 https://pharmadispatch.com/news/clinuvel-progresses-us-based-vitiligo-study 2022-05-10T20:42:01+10:00 https://pharmadispatch.com/news/rushing-to-start-the-hta-review-is-just-walking-into-a-trap 2022-05-11T14:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-looking-for-a-new-head-of-ethics-and-complia 2022-05-11T14:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-non-committal-on-need-to-delay-hta-review 2022-05-11T14:00:01+10:00 https://pharmadispatch.com/news/is-supply-a-sleeper-issue-with-two-major-changes-coming 2022-05-12T14:00:01+10:00 https://pharmadispatch.com/news/baa-says-start-again-on-hta-review-committee-and-proposes-candid 2022-05-12T14:00:01+10:00 https://pharmadispatch.com/news/genomics-groups-call-for-change-in-pre-election-statements 2022-05-12T14:04:01+10:00 https://pharmadispatch.com/news/industry-backed-plan-to-move-australian-biotechnology-into-the-f 2022-05-13T14:00:01+10:00 https://pharmadispatch.com/news/speakers-line-up-for-the-20222-biopharmadispatch-conference 2022-05-13T14:00:01+10:00 https://pharmadispatch.com/news/csl-expects-a-short-delay-in-closing-vifor-acquisition 2022-05-12T23:31:01+10:00 https://pharmadispatch.com/news/gilead-australia-wins-best-employer-australia-recognition 2022-05-13T03:43:01+10:00 https://pharmadispatch.com/news/prime-minister-singles-out-department-of-health-over-vaccine-mis 2022-05-14T21:26:01+10:00 https://pharmadispatch.com/news/illuminas-susan-tousi-on-the-genomics-potential-to-change-health 2022-05-16T14:00:01+10:00 https://pharmadispatch.com/news/lundbeck-australia-again-recognised-as-a-great-place-to-work 2022-05-15T18:38:01+10:00 https://pharmadispatch.com/news/biogen-confirms-new-leadership-for-australia-and-new-zealand-1 2022-05-16T14:00:01+10:00 https://pharmadispatch.com/news/prime-minister-singles-out-department-of-health-over-vaccine-mis 2022-05-15T18:38:01+10:00 https://pharmadispatch.com/news/gsk-launches-second-year-of-graduate-researcher-program-1 2022-05-15T18:38:01+10:00 https://pharmadispatch.com/news/election-implications-and-change-dominate-conference-discussion 2022-05-17T14:00:01+10:00 https://pharmadispatch.com/news/ena-respiratory-joins-initiative-to-boost-development-of-nasal-s 2022-05-17T15:13:01+10:00 https://pharmadispatch.com/news/organon-joins-the-list-of-companies-certified-as-a-great-place-t 2022-05-18T13:00:01+10:00 https://pharmadispatch.com/news/priceline-pharmacy-launches-new-styled-flagship-store 2022-05-18T13:00:01+10:00 https://pharmadispatch.com/news/everybody-wants-to-talk-about-faster-access-and-this-is-the-mome 2022-05-18T13:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-latest-corporate-social-responsibility-report 2022-05-18T13:00:01+10:00 https://pharmadispatch.com/news/the-sights-and-sounds-of-bpd-2022 2022-05-18T06:41:01+10:00 https://pharmadispatch.com/news/does-anyone-know-if-they-do-can-they-tell-me 2022-05-18T18:15:01+10:00 https://pharmadispatch.com/news/msd-australia-recognised-as-a-family-friendly-workplace 2022-05-19T14:00:01+10:00 https://pharmadispatch.com/news/bayer-seeks-local-applications-for-global-grants-program 2022-05-19T14:00:01+10:00 https://pharmadispatch.com/news/connecting-the-medicine-to-the-patient-is-what-matters 2022-05-19T14:00:01+10:00 https://pharmadispatch.com/news/medical-device-sector-welcomes-labor-commitment-to-manufacturing 2022-05-19T19:33:01+10:00 https://pharmadispatch.com/news/new-strategic-partnership-between-cabrini-and-bupa 2022-05-19T19:34:01+10:00 https://pharmadispatch.com/news/gmhba-commits-extra-support-to-members-waiting-for-surgery 2022-05-19T19:35:01+10:00 https://pharmadispatch.com/news/immutep-appoints-leading-oncologists-to-clinical-advisory-board 2022-05-19T19:56:01+10:00 https://pharmadispatch.com/news/starpharma-says-spl7013-in-viraleze-virucidal-against-influenza- 2022-05-19T20:00:01+10:00 https://pharmadispatch.com/news/anteotechs-updated-covid-19-rat-receives-regulatory-approval-in- 2022-05-19T20:04:01+10:00 https://pharmadispatch.com/news/fda-confirms-a-diagnostic-method-for-medibios-final-depression-v 2022-05-19T20:05:01+10:00 https://pharmadispatch.com/news/discussion-focused-on-structural-change-and-respectful-disagreem 2022-05-19T20:27:01+10:00 https://pharmadispatch.com/news/leading-public-affairs-consultants-share-their-election-predicti 2022-05-20T14:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-issues-major-party-election-commitments 2022-05-19T21:48:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-welcomes-labor-commitment-to-review-quality-use 2022-05-19T23:37:01+10:00 https://pharmadispatch.com/news/funding-boost-for-pharmac-but-not-news-on-review 2022-05-20T14:00:01+10:00 https://pharmadispatch.com/news/nsw-residents-report-decline-in-health-due-to-delayed-health-che 2022-05-20T14:00:01+10:00 https://pharmadispatch.com/news/work-to-begin-on-election-commitments-but-with-a-twist 2022-05-23T14:00:01+10:00 https://pharmadispatch.com/news/will-the-new-minister-bring-a-respectful-culture-to-decision-mak 2022-05-23T14:00:01+10:00 https://pharmadispatch.com/news/election-brings-change-and-a-focus-on-new-relationships 2022-05-23T14:00:01+10:00 https://pharmadispatch.com/news/the-mechanics-of-political-change-and-transition-to-a-new-minist 2022-05-23T03:26:01+10:00 https://pharmadispatch.com/news/new-government-to-provide-a-major-boost-for-medical-manufacturin 2022-05-24T14:00:01+10:00 https://pharmadispatch.com/news/change-is-underway-in-australiasultimate-company-town 2022-05-24T14:00:01+10:00 https://pharmadispatch.com/news/pfizer-and-merck-join-forces-to-raise-awareness-for-bladder-canc 2022-05-24T14:00:01+10:00 https://pharmadispatch.com/news/new-bone-health-audit-tool-aims-to-enhance-osteoporosis-care 2022-05-24T14:00:01+10:00 https://pharmadispatch.com/news/queensland-to-combat-flu-outbreak-with-free-vaccine-program 2022-05-24T14:00:01+10:00 https://pharmadispatch.com/news/new-report-recommends-inclusive-approach-to-horizon-scanning 2022-05-24T14:00:01+10:00 https://pharmadispatch.com/news/google-cloud-partners-with-garvan-to-accelerate-genome-sequencin 2022-05-24T17:53:01+10:00 https://pharmadispatch.com/news/medibank-extends-covid-support-for-ahm-customers 2022-05-24T17:55:01+10:00 https://pharmadispatch.com/news/mcia-releases-roadmap-to-growth-for-the-australian-medicinal-can 2022-05-24T17:56:01+10:00 https://pharmadispatch.com/news/a-new-minister-means-a-new-approach-and-new-priorities 2022-05-24T18:41:01+10:00 https://pharmadispatch.com/news/us-based-industry-sets-objectives-for-new-trade-alliance 2022-05-25T14:00:01+10:00 https://pharmadispatch.com/news/patient-voices-a-good-predictor-of-cancer-treatment-outcomes 2022-05-25T14:00:01+10:00 https://pharmadispatch.com/news/horizon-scanning-reflects-the-wider-impetus-for-change 2022-05-25T14:00:01+10:00 https://pharmadispatch.com/news/an-interesting-time-but-the-return-to-travel-is-happening-rapidl 2022-05-26T13:00:01+10:00 https://pharmadispatch.com/news/bupa-giving-customers-greater-transparency-and-choice 2022-05-25T20:13:01+10:00 https://pharmadispatch.com/news/new-plan-to-build-a-disability-confident-culture-at-medibank 2022-05-25T20:14:01+10:00 https://pharmadispatch.com/news/australian-dental-association-anticipates-change-in-aged-care 2022-05-25T20:15:01+10:00 https://pharmadispatch.com/news/new-clinical-trial-to-test-cancer-drug-in-motor-neuron-disease 2022-05-25T20:48:01+10:00 https://pharmadispatch.com/news/archer-materials-secures-australian-patent-for-quantum-computing 2022-05-25T20:49:01+10:00 https://pharmadispatch.com/news/anteris-technologies-expands-its-medical-advisory-board 2022-05-25T20:50:01+10:00 https://pharmadispatch.com/news/an-interesting-time-but-the-return-to-travel-is-happening-rapidl 2022-05-26T12:45:01+10:00 https://pharmadispatch.com/news/second-phase-of-consultation-open-on-discount-rate-review-1 2022-05-26T12:45:01+10:00 https://pharmadispatch.com/news/brandon-capital-backs-new-zealand-immunotherapy-start-up-1 2022-05-26T12:45:01+10:00 https://pharmadispatch.com/news/government-expands-access-to-covid-19-vaccine-booster-1 2022-05-26T12:45:01+10:00 https://pharmadispatch.com/news/why-is-disinvestment-now-mentioned-as-much-as-investment 2022-05-27T00:19:01+10:00 https://pharmadispatch.com/news/reviews-should-focus-on-delivering-access-in-100-days 2022-05-27T01:14:01+10:00 https://pharmadispatch.com/news/abbvie-appoints-country-head-for-new-zealand 2022-05-27T02:49:01+10:00 https://pharmadispatch.com/news/common-drug-offers-fertility-hope-for-women-with-obesity-1 2022-05-27T00:19:01+10:00 https://pharmadispatch.com/news/sanofi-developed-scanner-helping-educate-on-haemophilia 2022-05-30T11:00:01+10:00 https://pharmadispatch.com/news/finance-minister-confirms-a-new-era-of-fiscal-discipline-is-here 2022-05-30T11:00:01+10:00 https://pharmadispatch.com/news/the-new-reality-of-fiscal-consolidation-will-hit-discretionary-s 2022-05-30T11:00:01+10:00 https://pharmadispatch.com/news/first-powers-exercised-over-the-pbs-since-labors-election-win 2022-05-30T11:00:01+10:00 https://pharmadispatch.com/news/bms-australia-the-latest-to-earn-great-place-to-work-recognition 2022-05-30T11:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-starts-the-search-for-new-head-of-government 2022-05-31T04:12:01+10:00 https://pharmadispatch.com/news/where-exactly-is-the-final-report-of-the-pharmac-review 2022-05-31T04:47:01+10:00 https://pharmadispatch.com/news/new-liberal-party-leaders-bring-significant-experience-of-health 2022-05-31T05:02:01+10:00 https://pharmadispatch.com/news/janssens-biljana-naumovic-promoted-to-senior-global-role 2022-06-01T01:38:01+10:00 https://pharmadispatch.com/news/federal-anti-corruption-body-an-opportunity-to-drive-change-in-h 2022-06-01T03:06:01+10:00 https://pharmadispatch.com/news/experienced-market-access-executive-appointed-to-lead-takeda 2022-06-01T05:15:01+10:00 https://pharmadispatch.com/news/organisations-move-quickly-to-welcome-new-federal-ministry 2022-06-01T05:41:01+10:00 https://pharmadispatch.com/news/sandoz-launches-global-initiative-to-promote-biosimilars 2022-06-01T06:18:01+10:00 https://pharmadispatch.com/news/medicines-nz-warns-against-cherry-picking-and-meaningless-action 2022-06-02T05:58:01+10:00 https://pharmadispatch.com/news/stakeholders-right-to-be-concerned-by-review-response 2022-06-02T06:41:01+10:00 https://pharmadispatch.com/news/merck-shows-its-support-for-multiple-sclerosis-community 2022-06-02T07:32:01+10:00 https://pharmadispatch.com/news/sanofi-australia-in-industry-first-partnership-with-the-rum-proj 2022-06-02T12:52:01+10:00 https://pharmadispatch.com/news/pfizer-confirms-plan-to-exit-stake-in-consumer-health-business 2022-06-02T13:45:01+10:00 https://pharmadispatch.com/news/gilead-recognised-for-efforts-inlgbtq-workplace-inclusion 2022-06-03T03:13:01+10:00 https://pharmadispatch.com/news/roche-partners-on-the-redevelopment-of-office-rooftop-terrace 2022-06-03T03:25:01+10:00 https://pharmadispatch.com/news/a-knighthood-for-astrazenecas-australian-ceo 2022-06-03T04:14:01+10:00 https://pharmadispatch.com/news/free-flu-vaccine-programs-well-intentioned-but-not-without-chall 2022-06-03T04:59:01+10:00 https://pharmadispatch.com/news/mark-butlers-first-full-week-marked-by-legal-hearings-and-critic 2022-06-05T05:43:01+10:00 https://pharmadispatch.com/news/gilead-announces-recipients-of-2022-research-awards 2022-06-05T06:10:01+10:00 https://pharmadispatch.com/news/organon-celebrates-first-anniversary-with-impact-report 2022-06-05T06:28:01+10:00 https://pharmadispatch.com/news/opposition-sends-health-portfolio-to-the-senate 2022-06-06T14:41:01+10:00 https://pharmadispatch.com/news/short-hearing-reveals-the-government-plans-a-rigorous-defence 2022-06-07T06:48:01+10:00 https://pharmadispatch.com/news/we-only-know-about-this-one-because-the-company-has-never-given- 2022-06-07T07:21:01+10:00 https://pharmadispatch.com/news/emerging-frustrations-but-ma-confident-of-positive-progress 2022-06-07T08:51:01+10:00 https://pharmadispatch.com/news/nominations-open-for-gsks-award-for-research-excellence 2022-06-07T13:25:01+10:00 https://pharmadispatch.com/news/bupa-announces-new-virtual-and-in-home-partnership-with-mater-he 2022-06-07T14:35:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-priorities-in-first-interview-as-health-min 2022-06-07T14:37:01+10:00 https://pharmadispatch.com/news/mark-butler-starts-the-process-of-building-ministerial-office 2022-06-08T12:08:01+10:00 https://pharmadispatch.com/news/australian-women-at-risk-of-cancer-missing-out-on-genetic-testin 2022-06-08T12:32:01+10:00 https://pharmadispatch.com/news/uk-again-leads-the-way-on-early-access-with-new-innovative-medic 2022-06-08T13:00:01+10:00 https://pharmadispatch.com/news/the-uk-shows-the-way-forward-on-accelerating-patient-access 2022-06-08T13:16:01+10:00 https://pharmadispatch.com/news/msd-plans-campaign-to-raise-awareness-of-oral-covid-treatments 2022-06-09T06:14:01+10:00 https://pharmadispatch.com/news/nz-health-minister-unloads-on-australia-over-his-nursing-shortag 2022-06-09T06:51:01+10:00 https://pharmadispatch.com/news/biontech-trial-gives-hope-for-pancreatic-cancer-vaccine 2022-06-09T12:46:01+10:00 https://pharmadispatch.com/news/medicines-australia-issues-conversation-starter-for-hta-review 2022-06-10T10:01:01+10:00 https://pharmadispatch.com/news/key-highlights-from-the-medicines-australia-conversation-starter 2022-06-10T10:19:01+10:00 https://pharmadispatch.com/news/medicinal-cannabis-association-looks-to-policy-progress-with-new 2022-06-10T10:39:01+10:00 https://pharmadispatch.com/news/patients-push-for-funding-of-new-car-t-blood-cancer-therapy 2022-06-10T10:55:01+10:00 https://pharmadispatch.com/news/major-promotion-for-organon-australia-senior-executive 2022-06-10T11:09:01+10:00 https://pharmadispatch.com/news/ironically-the-wto-is-only-debating-a-waiver-because-of-the-posi 2022-06-14T13:00:01+10:00 https://pharmadispatch.com/news/ma-slams-compromise-agreement-on-covid-ip-waiver 2022-06-14T13:00:01+10:00 https://pharmadispatch.com/news/organons-susanne-fiedler-on-the-opportunity-to-help-build-a-new- 2022-06-14T13:00:01+10:00 https://pharmadispatch.com/news/government-tells-the-industry-to-manage-supply-ahead-of-october- 2022-06-14T13:00:01+10:00 https://pharmadispatch.com/news/new-snapshot-reveals-significant-growth-for-australian-biotechno 2022-06-14T14:22:01+10:00 https://pharmadispatch.com/news/tga-authorises-advertising-of-covid-19-oral-treatments-but-with- 2022-06-15T00:54:01+10:00 https://pharmadispatch.com/news/progress-for-key-gene-therapies-after-multiple-setbacks 2022-06-15T14:00:01+10:00 https://pharmadispatch.com/news/australian-company-says-clinical-trial-validates-targeting-lsd1- 2022-06-15T14:00:01+10:00 https://pharmadispatch.com/news/minister-makes-the-case-for-investment-in-australias-social-prog 2022-06-15T13:00:01+10:00 https://pharmadispatch.com/news/tga-approves-adult-booster-dose-of-novavax-covid-19-vaccine 2022-06-15T14:00:01+10:00 https://pharmadispatch.com/news/the-challenge-of-dealing-with-the-day-to-day-while-remaining-foc 2022-06-16T02:07:01+10:00 https://pharmadispatch.com/news/major-acquisition-for-leading-australian-company 2022-06-16T03:13:01+10:00 https://pharmadispatch.com/news/new-treatments-help-drive-improvements-in-childhood-cancer-survi 2022-06-16T14:27:01+10:00 https://pharmadispatch.com/news/uk-officially-implements-world-first-antibiotic-subscription-mod 2022-06-17T14:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-focus-on-emerging-cancer-diagnostics-and-tr 2022-06-17T01:55:01+10:00 https://pharmadispatch.com/news/minister-that-is-what-you-have-been-told-but-it-is-not-what-we-a 2022-06-17T14:49:01+10:00 https://pharmadispatch.com/news/psa-national-board-elects-first-female-national-president 2022-06-17T15:09:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-focus-on-emerging-cancer-diagnostics-and-tr 2022-06-17T14:00:01+10:00 https://pharmadispatch.com/news/research-based-industry-says-ip-waiver-an-empty-shell-and-fact-f 2022-06-19T23:12:01+10:00 https://pharmadispatch.com/news/annual-cost-recovery-statement-anticipates-higher-fees 2022-06-20T14:00:01+10:00 https://pharmadispatch.com/news/the-embarrassing-case-against-a-major-labor-election-commitment 2022-06-19T14:00:01+10:00 https://pharmadispatch.com/news/kyowa-kirin-welcomes-recommendation-from-pbac-may-intracycle-1 2022-06-19T22:44:01+10:00 https://pharmadispatch.com/news/biogen-awarded-great-place-to-work-certification-for-a-second-st 2022-06-20T21:19:01+10:00 https://pharmadispatch.com/news/seriously-can-the-people-arguing-against-this-actually-hear-them 2022-06-20T22:42:01+10:00 https://pharmadispatch.com/news/insight-strategys-jody-fassina-on-the-final-senate-composition 2022-06-21T14:00:01+10:00 https://pharmadispatch.com/news/gsk-boss-shares-industry-insights-and-experiences-with-research- 2022-06-21T14:00:01+10:00 https://pharmadispatch.com/news/what-now-for-election-commitments-and-other-new-spending-proposa 2022-06-22T13:00:01+10:00 https://pharmadispatch.com/news/rca-marks-ten-year-anniversary-and-prepares-to-farewell-co-found 2022-06-22T13:18:01+10:00 https://pharmadispatch.com/news/i-think-countries-havent-done-this-lightly-says-mark-butler-on-i 2022-06-22T14:08:01+10:00 https://pharmadispatch.com/news/novavax-global-chief-medical-officer-on-expecting-the-unexpected 2022-06-22T23:01:01+10:00 https://pharmadispatch.com/news/ma-says-no-surprise-if-hta-review-timelines-are-impacted 2022-06-23T02:31:01+10:00 https://pharmadispatch.com/news/seqirus-presents-real-world-data-on-cell-based-flu-vaccines 2022-06-23T02:49:01+10:00 https://pharmadispatch.com/news/supporting-reform-means-not-mouthing-the-same-excuses-used-to-de 2022-06-23T21:34:01+10:00 https://pharmadispatch.com/news/supporting-reform-means-not-mouthing-the-same-excuses-used-to-de 2022-06-23T14:31:01+10:00 https://pharmadispatch.com/news/should-time-to-access-be-considered-a-fundamental-human-right-1 2022-06-24T14:31:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-support-for-industry-in-state-budgets-1 2022-06-24T14:31:01+10:00 https://pharmadispatch.com/news/new-senior-appointments-formedicines-australia-1 2022-06-27T03:17:01+10:00 https://pharmadispatch.com/news/call-for-action-to-address-low-awareness-of-heart-failure-1 2022-06-27T03:17:01+10:00 https://pharmadispatch.com/news/novartis-to-consolidate-production-of-car-t-therapy-in-the-us 2022-06-27T03:17:01+10:00 https://pharmadispatch.com/news/lilly-secures-another-nomination-for-annual-australian-hr-awards 2022-06-28T14:00:01+10:00 https://pharmadispatch.com/news/is-the-budget-process-intended-to-undermine-election-commitments 2022-06-29T14:00:01+10:00 https://pharmadispatch.com/news/what-does-it-mean-when-the-system-cannot-even-call-patients-by-t 2022-06-28T02:23:01+10:00 https://pharmadispatch.com/news/new-zealand-expands-access-to-free-seasonal-flu-vaccine 2022-06-28T04:04:01+10:00 https://pharmadispatch.com/news/bi-recruits-sanofi-executive-to-head-new-corporate-affairs-funct 2022-06-29T14:00:01+10:00 https://pharmadispatch.com/news/mark-butler-says-reform-of-newborn-screening-is-happening 2022-06-29T02:24:01+10:00 https://pharmadispatch.com/news/election-commitment-could-be-lost-to-october-budget-process 2022-06-29T02:18:01+10:00 https://pharmadispatch.com/news/pfizer-leaders-sleep-rough-in-support-of-vinnies-ceo-sleepout 2022-06-29T14:00:01+10:00 https://pharmadispatch.com/news/out-with-the-old-industry-agreements-and-in-with-the-new 2022-06-30T14:00:01+10:00 https://pharmadispatch.com/news/industry-says-perpetuity-requirement-will-undermine-early-access 2022-06-30T14:00:01+10:00 https://pharmadispatch.com/news/digital-clinical-trial-recruitment-platform-in-new-agreements-wi 2022-06-30T14:00:01+10:00 https://pharmadispatch.com/news/the-halton-review-likely-to-be-the-first-of-many-on-pandemic-per 2022-07-01T14:00:01+10:00 https://pharmadispatch.com/news/bayer-secures-new-pbs-listing-with-medicare-funded-diagnostic 2022-07-01T14:00:01+10:00 https://pharmadispatch.com/news/abbvie-delivers-in-its-annual-month-of-possibilities-volunteerin 2022-07-01T14:00:01+10:00 https://pharmadispatch.com/news/beigene-welcomes-expanded-listing-for-targeted-blood-cancer-ther 2022-07-01T04:03:01+10:00 https://pharmadispatch.com/news/over-1000-medicines-facing-catch-up-reductions-in-april 2022-07-01T15:20:01+10:00 https://pharmadispatch.com/news/the-health-system-review-that-is-not-even-being-led-by-health 2022-07-04T13:00:01+10:00 https://pharmadispatch.com/news/few-should-expect-ministerial-discretion-and-few-should-actually 2022-07-04T13:00:01+10:00 https://pharmadispatch.com/news/novartis-considers-spin-out-of-sandoz-off-patent-division 2022-07-04T13:00:01+10:00 https://pharmadispatch.com/news/pre-budget-spending-rules-not-quite-that-strict-after-all 2022-07-04T14:00:01+10:00 https://pharmadispatch.com/news/lung-cancer-screening-would-save-lives-but-too-expensive 2022-07-03T23:36:01+10:00 https://pharmadispatch.com/news/this-is-what-health-technology-assessment-has-become-in-australi 2022-07-05T13:00:01+10:00 https://pharmadispatch.com/news/tga-authorises-government-campaign-promoting-covid-19-treatments 2022-07-04T23:15:01+10:00 https://pharmadispatch.com/news/australian-researchers-identify-new-drug-target-for-inflammatory 2022-07-05T14:00:01+10:00 https://pharmadispatch.com/news/more-regulation-and-more-bureaucracy-is-not-the-solution 2022-07-05T21:44:01+10:00 https://pharmadispatch.com/news/teachers-health-reopens-state-of-the-art-facility-in-sydney 2022-07-05T21:45:01+10:00 https://pharmadispatch.com/news/csiro-supports-cureator-with-funding-for-health-security-stream 2022-07-05T21:46:01+10:00 https://pharmadispatch.com/news/dimerix-updates-with-new-and-positive-dmx-700-data 2022-07-05T21:47:01+10:00 https://pharmadispatch.com/news/noxopharm-adds-three-new-us-sites-to-cep-2-sarcoma-study 2022-07-05T21:48:01+10:00 https://pharmadispatch.com/news/biomarin-now-looks-to-reimbursement-of-short-stature-therapy 2022-07-06T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-prescribing-of-pbs-listed-covid-treatments-too-restr 2022-07-06T02:00:01+10:00 https://pharmadispatch.com/news/new-appointments-for-expanding-red-havas-health 2022-07-06T14:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-in-regular-contact-on-major-priorities 2022-07-06T03:10:01+10:00 https://pharmadispatch.com/news/australian-study-uncovers-a-driving-factor-in-the-development-of 2022-07-07T13:00:01+10:00 https://pharmadispatch.com/news/pharmac-inviting-new-proposals-for-advanced-lung-cancer-again 2022-07-07T13:00:01+10:00 https://pharmadispatch.com/news/tga-grants-provisional-determination-for-pfizers-two-omicron-vac 2022-07-07T13:00:01+10:00 https://pharmadispatch.com/news/the-legal-quirk-of-technology-history-is-a-much-bigger-problem-t 2022-07-08T13:00:01+10:00 https://pharmadispatch.com/news/industry-slams-us-agreement-on-allowing-price-negotiation 2022-07-08T13:00:01+10:00 https://pharmadispatch.com/news/governments-and-companies-discarding-million-of-vaccine-doses 2022-07-08T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-wider-access-to-fourth-covid-19-vaccine-dos 2022-07-08T14:00:01+10:00 https://pharmadispatch.com/news/election-commitment-outsourced-to-nmp-management-consultant 2022-07-10T19:57:01+10:00 https://pharmadispatch.com/news/pbac-recommended-wider-access-before-last-weeks-meeting 2022-07-11T13:00:01+10:00 https://pharmadispatch.com/news/australia-widens-access-to-treatments-but-the-us-authorises-phar 2022-07-11T13:00:01+10:00 https://pharmadispatch.com/news/apparently-we-now-need-management-consultants-to-make-policy-dec 2022-07-11T13:00:01+10:00 https://pharmadispatch.com/news/emerging-australian-company-appoints-industry-research-leader-to 2022-07-12T13:00:01+10:00 https://pharmadispatch.com/news/auditor-general-proposes-first-system-level-audit-of-pbs-since-1 2022-07-12T13:00:01+10:00 https://pharmadispatch.com/news/jazz-pharmaceuticals-welcomes-registration-of-new-aml-treatment 2022-07-12T13:00:01+10:00 https://pharmadispatch.com/news/new-review-of-nps-medicinewise-a-re-run-of-previous-process 2022-07-13T13:00:01+10:00 https://pharmadispatch.com/news/no-end-to-reviews-but-the-proposed-audit-is-the-one-that-will-al 2022-07-13T13:00:01+10:00 https://pharmadispatch.com/news/pharmacists-challenge-failure-to-extend-free-rat-program 2022-07-13T13:00:01+10:00 https://pharmadispatch.com/news/roche-marks-125-year-anniversary-with-health-charity-grants-prog 2022-07-13T01:34:01+10:00 https://pharmadispatch.com/news/medibank-partners-to-accelerate-access-to-mental-health-services 2022-07-13T19:35:01+10:00 https://pharmadispatch.com/news/telix-pharmaceuticals-announces-major-leadership-appointment 2022-07-13T19:36:01+10:00 https://pharmadispatch.com/news/study-identifies-kids-with-cancer-at-risk-of-lethal-infections 2022-07-13T19:37:01+10:00 https://pharmadispatch.com/news/neuroscientific-biopharmaceuticals-seeks-approval-for-phase-1-tr 2022-07-13T19:38:01+10:00 https://pharmadispatch.com/news/bupa-supporting-the-growth-of-kids-helpline-school 2022-07-13T20:10:01+10:00 https://pharmadispatch.com/news/doctor-groups-call-for-urgent-reinstatement-of-covid-19-teleheal 2022-07-13T20:11:01+10:00 https://pharmadispatch.com/news/government-says-challenging-budget-behind-decision-on-tests 2022-07-14T13:00:01+10:00 https://pharmadispatch.com/news/officials-getting-a-practical-but-harsh-lesson-on-supplying-medi 2022-07-13T22:09:01+10:00 https://pharmadispatch.com/news/government-preparing-for-consultation-on-chemotherapy-review 2022-07-14T13:00:01+10:00 https://pharmadispatch.com/news/major-regional-promotion-for-the-local-head-of-baxter 2022-07-14T02:37:01+10:00 https://pharmadispatch.com/news/federal-government-provides-financial-support-to-online-cancer-h 2022-07-14T03:29:01+10:00 https://pharmadispatch.com/news/cost-co-pay-reduction-will-be-partially-offset-by-revenue-from-r 2022-07-15T13:00:01+10:00 https://pharmadispatch.com/news/government-confirms-no-go-on-hta-review-reference-committee 2022-07-14T23:53:01+10:00 https://pharmadispatch.com/news/illumina-among-the-first-to-receive-approval-of-science-based-ne 2022-07-15T03:50:01+10:00 https://pharmadispatch.com/news/why-bother-the-hta-review-if-the-system-can-already-do-almost-an 2022-07-18T13:00:01+10:00 https://pharmadispatch.com/news/a-deeply-problematic-situation-caused-by-officials-making-it-up- 2022-07-18T13:00:01+10:00 https://pharmadispatch.com/news/government-relents-on-pandemic-response-as-data-reveals-spike-in 2022-07-18T13:00:01+10:00 https://pharmadispatch.com/news/ausbiotechs-lorraine-chiroiu-a-hollow-victory-and-slap-in-the-fa 2022-07-18T20:18:01+10:00 https://pharmadispatch.com/news/this-is-just-the-latest-example-of-selective-decision-making 2022-07-19T13:00:01+10:00 https://pharmadispatch.com/news/accc-clears-pfizer-acquisition-of-australian-digital-health-comp 2022-07-18T23:11:01+10:00 https://pharmadispatch.com/news/industry-gets-behind-annual-foodbank-week-of-care-event 2022-07-18T23:31:01+10:00 https://pharmadispatch.com/news/tga-tick-for-modernas-paediatric-dose-of-covid-19-vaccine 2022-07-19T21:22:01+10:00 https://pharmadispatch.com/news/australian-company-one-step-closer-to-major-product-launch 2022-07-19T21:38:01+10:00 https://pharmadispatch.com/news/rare-cancers-and-medicines-australia-weigh-in-on-expedited-reimb 2022-07-20T02:11:01+10:00 https://pharmadispatch.com/news/the-reality-of-entering-a-era-of-fiscal-consolidation 2022-07-21T13:00:01+10:00 https://pharmadispatch.com/news/building-real-world-evidence-the-goal-of-new-collaboration 2022-07-21T13:00:01+10:00 https://pharmadispatch.com/news/australias-first-national-biotechnology-incubator-announces-roun 2022-07-21T14:00:01+10:00 https://pharmadispatch.com/news/one-week-to-apply-for-relief-from-catch-up-price-reductions 2022-07-22T13:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-preparing-for-new-board-election 2022-07-22T13:00:01+10:00 https://pharmadispatch.com/news/reductions-make-biosimilars-more-expensive-than-the-originator 2022-07-22T13:00:01+10:00 https://pharmadispatch.com/news/telix-surges-on-us-launch-and-sales-of-nuclear-medicine-therapy 2022-07-22T13:00:01+10:00 https://pharmadispatch.com/news/government-turns-to-wholesalers-to-manage-stockpiling-risk-ahead 2022-07-25T14:00:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-makes-bizarre-claim-over-shortages 2022-07-25T13:00:01+10:00 https://pharmadispatch.com/news/ma-and-gbma-consider-seeking-extension-to-accc-supply-authorisat 2022-07-25T13:00:01+10:00 https://pharmadispatch.com/news/insight-strategys-jody-fassina-on-the-47th-parliament 2022-07-25T13:00:01+10:00 https://pharmadispatch.com/news/physiotherapists-call-for-greater-support-to-address-long-covid 2022-07-25T20:19:01+10:00 https://pharmadispatch.com/news/annual-survey-confirms-increase-in-private-health-insurance-cove 2022-07-25T20:20:01+10:00 https://pharmadispatch.com/news/nib-launches-anaesthetics-network-with-plans-for-national-expans 2022-07-25T20:22:01+10:00 https://pharmadispatch.com/news/transparency-legislation-officially-lapses-but-it-could-return 2022-07-26T13:00:01+10:00 https://pharmadispatch.com/news/former-governments-manufacturing-commitments-under-review 2022-07-26T13:00:01+10:00 https://pharmadispatch.com/news/industry-responds-to-waiver-with-its-own-access-declaration 2022-07-26T13:00:01+10:00 https://pharmadispatch.com/news/new-approval-for-the-biocelect-novavax-covid-19-vaccine 2022-07-26T13:00:01+10:00 https://pharmadispatch.com/news/this-dispute-is-exactly-why-changes-need-proper-scrutiny 2022-07-27T13:00:01+10:00 https://pharmadispatch.com/news/dispute-over-catch-up-reductions-grows-as-deadline-nears 2022-07-27T13:00:01+10:00 https://pharmadispatch.com/news/perverse-outcomes-does-not-make-the-interpretation-wrong 2022-07-27T13:00:01+10:00 https://pharmadispatch.com/news/the-current-issue-with-catch-ups-was-raised-last-year-but-dismis 2022-07-28T13:00:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-policy-the-detail-is-what-matters 2022-07-28T13:00:01+10:00 https://pharmadispatch.com/news/tga-launches-legal-action-over-illegal-promotion-of-nicotine-vap 2022-07-28T13:00:01+10:00 https://pharmadispatch.com/news/new-survey-confirms-the-internet-as-a-first-stop-for-health-advi 2022-07-28T13:00:01+10:00 https://pharmadispatch.com/news/published-agenda-reveals-slim-list-for-november-committee-meetin 2022-07-28T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-officially-calls-time-on-bill-to-scrap-confidentiali 2022-07-28T20:36:01+10:00 https://pharmadispatch.com/news/the-revealing-public-exchange-that-should-have-alarmed-the-indus 2022-07-29T13:00:01+10:00 https://pharmadispatch.com/news/this-fight-on-catch-ups-would-have-been-much-easier-to-win-last- 2022-07-29T13:00:01+10:00 https://pharmadispatch.com/news/tga-refutes-claim-it-removed-rapid-antigen-tests-over-omicron-fa 2022-07-29T02:21:01+10:00 https://pharmadispatch.com/news/legal-arguments-will-fail-because-companies-do-not-want-the-law- 2022-07-29T13:00:01+10:00 https://pharmadispatch.com/news/api-and-sector-leader-to-step-away-following-wesfarmers-integrat 2022-08-01T13:00:01+10:00 https://pharmadispatch.com/news/nurse-led-organisation-seeking-donations-in-response-to-stalled- 2022-08-01T13:00:01+10:00 https://pharmadispatch.com/news/major-day-for-biogen-with-two-significant-pbs-listings 2022-08-01T12:00:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-restart-of-nmp-review-in-first-health-secto 2022-08-01T13:00:01+10:00 https://pharmadispatch.com/news/tobacco-company-tries-again-with-nicotine-vaping-and-pharmacy 2022-08-02T13:00:01+10:00 https://pharmadispatch.com/news/is-this-relationship-on-nicotine-vaping-really-worth-the-risk 2022-08-02T13:00:01+10:00 https://pharmadispatch.com/news/new-business-unit-director-for-novo-nordisk 2022-08-02T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-a-member-of-key-cabinet-sub-committee 2022-08-03T13:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-confirms-the-appointment-of-new-gr-head 2022-08-02T02:37:01+10:00 https://pharmadispatch.com/news/beigene-appoints-new-medical-director-for-australia-and-nz 2022-08-02T06:20:01+10:00 https://pharmadispatch.com/news/baxter-healthcare-announces-new-general-manager 2022-08-02T13:00:01+10:00 https://pharmadispatch.com/news/annual-report-reveals-dramatic-growth-in-private-covid-claims 2022-08-02T18:29:01+10:00 https://pharmadispatch.com/news/epworth-the-first-private-hospital-to-offer-pancreatic-cancer-tr 2022-08-02T18:33:01+10:00 https://pharmadispatch.com/news/election-of-new-national-leadership-for-the-ama 2022-08-02T18:35:01+10:00 https://pharmadispatch.com/news/bupa-dental-urges-action-on-oral-health-for-dental-health-week 2022-08-02T18:36:01+10:00 https://pharmadispatch.com/news/perplexed-by-the-focus-on-cost-of-lung-cancer-screening 2022-08-03T13:00:01+10:00 https://pharmadispatch.com/news/department-hiding-the-number-of-applications-for-ministerial-dis 2022-08-02T21:00:01+10:00 https://pharmadispatch.com/news/industry-catalyst-launches-next-phase-of-cell-and-gene-collabora 2022-08-03T13:00:01+10:00 https://pharmadispatch.com/news/the-challenge-is-to-assess-changes-based-on-the-worst-possible-o 2022-08-03T02:38:01+10:00 https://pharmadispatch.com/news/immutep-reports-new-data-from-phase-2-tacti-002-trial 2022-08-03T03:26:01+10:00 https://pharmadispatch.com/news/recruitment-open-for-new-study-of-lung-disease 2022-08-03T03:28:01+10:00 https://pharmadispatch.com/news/new-study-published-demonstrating-the-utility-of-promarkerd-test 2022-08-03T03:29:01+10:00 https://pharmadispatch.com/news/lumos-diagnostics-announces-plan-to-close-us-facility 2022-08-03T03:30:01+10:00 https://pharmadispatch.com/news/want-equal-pay-the-odds-are-better-in-new-zealand 2022-08-03T20:03:01+10:00 https://pharmadispatch.com/news/pfizer-raises-offer-for-australian-digital-health-company 2022-08-04T13:00:01+10:00 https://pharmadispatch.com/news/pharmacy-demands-no-place-for-tobacco-in-health-system 2022-08-04T13:00:01+10:00 https://pharmadispatch.com/news/government-confirms-paediatric-access-to-covid-19-vaccine 2022-08-04T13:00:01+10:00 https://pharmadispatch.com/news/department-switches-excuse-to-block-release-of-a-simple-number 2022-08-05T13:00:01+10:00 https://pharmadispatch.com/news/bupa-and-ramsay-to-continue-contract-negotiations 2022-08-04T23:00:01+10:00 https://pharmadispatch.com/news/nib-offers-its-employees-a-new-range-of-benefits 2022-08-04T23:01:01+10:00 https://pharmadispatch.com/news/medical-developments-international-announces-fully-underwritten- 2022-08-04T23:02:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-announces-new-agreements-with-lantheus-a 2022-08-04T23:03:01+10:00 https://pharmadispatch.com/news/osteopore-secures-us-distribution-agreement-for-government-facil 2022-08-04T23:05:01+10:00 https://pharmadispatch.com/news/rapid-review-of-budget-decision-has-been-nothing-if-not-rapid 2022-08-04T23:25:01+10:00 https://pharmadispatch.com/news/green-whistle-maker-announces-capital-raise-and-sales-growth 2022-08-05T00:31:01+10:00 https://pharmadispatch.com/news/government-secures-monkeypox-vaccine-from-danish-company 2022-08-05T13:00:01+10:00 https://pharmadispatch.com/news/the-result-of-a-process-that-started-badly-and-only-got-worse 2022-08-08T13:00:01+10:00 https://pharmadispatch.com/news/mark-butler-must-be-very-confused-by-this-situation 2022-08-07T20:33:01+10:00 https://pharmadispatch.com/news/what-needs-to-change-to-ensure-this-never-happens-again 2022-08-08T13:00:01+10:00 https://pharmadispatch.com/news/industry-says-backing-for-us-pricing-reform-a-tragic-loss-for-pa 2022-08-09T13:00:01+10:00 https://pharmadispatch.com/news/stcounsel-accuses-commonwealth-witnesses-of-evasive-responses-to 2022-08-09T13:00:01+10:00 https://pharmadispatch.com/news/sanofi-starts-installing-solar-panels-at-manufacturing-facility 2022-08-09T13:00:01+10:00 https://pharmadispatch.com/news/what-other-government-records-are-officials-destroying 2022-08-09T13:00:01+10:00 https://pharmadispatch.com/news/blood-cancer-taskforce-launches-optimal-care-pathways 2022-08-09T13:00:01+10:00 https://pharmadispatch.com/news/an-outcome-that-disadvantages-the-respondent-is-not-relevant 2022-08-10T13:00:01+10:00 https://pharmadispatch.com/news/companies-hist-hard-by-the-new-price-cut-flow-on-mechanisms 2022-08-10T13:00:01+10:00 https://pharmadispatch.com/news/victorias-first-mrna-innovation-hub-backed-by-state-government 2022-08-10T13:00:01+10:00 https://pharmadispatch.com/news/competition-regulator-authorises-honeysuckle-health-to-establish 2022-08-10T01:52:01+10:00 https://pharmadispatch.com/news/hcf-and-ramsay-announce-collaboration-to-develop-new-care-models 2022-08-10T01:54:01+10:00 https://pharmadispatch.com/news/helping-doctors-reduce-out-of-pocket-expenses-for-patients 2022-08-10T01:55:01+10:00 https://pharmadispatch.com/news/lumos-withdraws-from-participation-in-victorian-manufacturing-pr 2022-08-10T01:58:01+10:00 https://pharmadispatch.com/news/neuren-commences-enrolment-new-phase-2-trials-of-nnz-2591 2022-08-10T02:00:01+10:00 https://pharmadispatch.com/news/telix-and-uq-led-consortium-awarded-australian-research-council- 2022-08-10T02:01:01+10:00 https://pharmadispatch.com/news/dimerix-announces-new-patent-family-for-dmx-700 2022-08-10T02:02:01+10:00 https://pharmadispatch.com/news/paig-announces-pay-it-forward-session-as-part-of-new-look-progra 2022-08-10T13:00:01+10:00 https://pharmadispatch.com/news/tga-registration-for-roche-innovative-eye-therapy 2022-08-10T13:00:01+10:00 https://pharmadispatch.com/news/critical-decisions-over-two-months-and-four-sitting-weeks 2022-08-11T13:00:01+10:00 https://pharmadispatch.com/news/uk-push-to-lead-the-world-on-genetic-profiling-of-cancer-patient 2022-08-11T13:00:01+10:00 https://pharmadispatch.com/news/msd-in-new-agreements-with-australian-company-starpharma 2022-08-11T13:00:01+10:00 https://pharmadispatch.com/news/bio-says-fewer-cures-the-only-certain-outcome-of-price-controls 2022-08-11T13:00:01+10:00 https://pharmadispatch.com/news/the-administration-of-the-process-is-as-important-as-the-process 2022-08-12T13:00:01+10:00 https://pharmadispatch.com/news/csiro-opens-missing-link-lab-to-developing-australian-vaccine-pi 2022-08-12T13:00:01+10:00 https://pharmadispatch.com/news/new-report-promotes-expansion-of-short-stay-hospital-program 2022-08-11T23:49:01+10:00 https://pharmadispatch.com/news/compare-the-market-investor-moves-to-acquire-all-of-iselect 2022-08-11T23:52:01+10:00 https://pharmadispatch.com/news/scrapped-covidsafe-app-only-identified-two-positive-cases 2022-08-11T23:53:01+10:00 https://pharmadispatch.com/news/partrys-candidate-in-combination-improves-survival-in-brain-canc 2022-08-11T23:56:01+10:00 https://pharmadispatch.com/news/first-patient-enrolled-in-new-trial-of-novosorb-synpath-treatmen 2022-08-11T23:58:01+10:00 https://pharmadispatch.com/news/pharmacy-says-follow-other-countries-on-covid-19-antivirals 2022-08-12T13:00:01+10:00 https://pharmadispatch.com/news/csl-announces-plan-to-rename-vifor-and-seqirus 2022-08-12T13:00:01+10:00 https://pharmadispatch.com/news/no-need-to-go-negative-on-review-just-be-realistic-and-prepared 2022-08-15T13:00:01+10:00 https://pharmadispatch.com/news/policy-horizon-scanning-will-add-more-value-than-the-product-ver 2022-08-15T13:00:01+10:00 https://pharmadispatch.com/news/budget-rules-are-confidential-but-the-language-is-revealing 2022-08-15T13:00:01+10:00 https://pharmadispatch.com/news/post-budget-summit-a-critical-time-for-serious-discussions 2022-08-15T01:10:01+10:00 https://pharmadispatch.com/news/no-answers-on-the-destruction-of-official-documents 2022-08-16T13:00:01+10:00 https://pharmadispatch.com/news/major-capital-raise-for-opthea-as-it-prepares-for-commercialisat 2022-08-16T13:00:01+10:00 https://pharmadispatch.com/news/new-zealand-edges-closer-to-funding-cystic-fibrosis-therapy 2022-08-16T13:00:01+10:00 https://pharmadispatch.com/news/monash-university-the-location-for-moderna-manufacturing-facilit 2022-08-16T13:00:01+10:00 https://pharmadispatch.com/news/viiv-healthcare-backs-research-translating-research-into-plain-s 2022-08-16T15:00:01+10:00 https://pharmadispatch.com/news/bupa-and-ramsay-resolve-dispute-over-new-hospital-agreement 2022-08-16T18:57:01+10:00 https://pharmadispatch.com/news/medibank-and-ahm-extend-age-for-adult-dependants-to-31 2022-08-16T18:59:01+10:00 https://pharmadispatch.com/news/process-transparency-is-important-because-it-is-their-greatest-f 2022-08-17T13:00:01+10:00 https://pharmadispatch.com/news/carina-biotech-capital-raise-backed-by-new-cornerstone-investor 2022-08-16T21:18:01+10:00 https://pharmadispatch.com/news/microbio-receives-clearance-to-sell-in-vitro-diagnostic-test-in- 2022-08-16T21:19:01+10:00 https://pharmadispatch.com/news/avita-medical-announces-topline-results-for-recell-system-trial 2022-08-16T21:20:01+10:00 https://pharmadispatch.com/news/epiaxis-therapeutics-and-peptilogics-announce-new-collaboration 2022-08-16T21:22:01+10:00 https://pharmadispatch.com/news/the-formal-process-does-not-mean-decision-makers-cannot-meet 2022-08-17T13:00:01+10:00 https://pharmadispatch.com/news/submission-argues-against-the-release-of-information-that-is-cur 2022-08-16T23:51:01+10:00 https://pharmadispatch.com/news/csl-looking-to-strong-post-pandemic-growth 2022-08-17T19:39:01+10:00 https://pharmadispatch.com/news/will-restarted-nmp-review-be-better-than-the-first-attempt 2022-08-18T13:00:01+10:00 https://pharmadispatch.com/news/csl-starts-planning-to-submit-no-antibody-treatment 2022-08-18T13:00:01+10:00 https://pharmadispatch.com/news/companies-make-the-list-of-australias-great-place-to-work 2022-08-18T14:00:01+10:00 https://pharmadispatch.com/news/new-report-has-laid-bare-the-failures-of-vaccine-rollout 2022-08-18T13:00:01+10:00 https://pharmadispatch.com/news/viatris-opens-new-production-lines-in-queensland 2022-08-18T13:00:01+10:00 https://pharmadispatch.com/news/the-appearance-of-a-pricing-policy-targeting-one-group-of-treatm 2022-08-19T13:00:01+10:00 https://pharmadispatch.com/news/first-speakers-confirmed-for-bpd-post-budget-summit 2022-08-19T14:00:01+10:00 https://pharmadispatch.com/news/telix-revenue-soars-after-us-commercialisation 2022-08-19T00:20:01+10:00 https://pharmadispatch.com/news/if-its-not-the-intent-it-is-certainly-an-extraordinary-coinciden 2022-08-19T14:00:01+10:00 https://pharmadispatch.com/news/the-industry-might-be-paying-the-price-for-the-failure-of-its-la 2022-08-23T12:00:01+10:00 https://pharmadispatch.com/news/jazz-taps-well-known-executive-to-lead-australia-and-nz 2022-08-22T13:00:01+10:00 https://pharmadispatch.com/news/review-coming-for-pbs-listed-type-2-diabetes-medicines 2022-08-22T13:00:01+10:00 https://pharmadispatch.com/news/slim-pickings-for-sponsors-in-july-pbac-outcomes 2022-08-22T13:00:01+10:00 https://pharmadispatch.com/news/bayer-now-working-towards-pbs-listing-of-heart-failure-treatment 2022-08-22T12:06:01+10:00 https://pharmadispatch.com/news/pharmac-expands-access-to-treatment-after-two-year-wait 2022-08-22T12:00:01+10:00 https://pharmadispatch.com/news/a-targeted-consultation-process-for-restarted-nmp-review 2022-08-23T13:00:01+10:00 https://pharmadispatch.com/news/tga-issues-another-provisional-determination-for-a-covid-19-trea 2022-08-23T13:00:01+10:00 https://pharmadispatch.com/news/what-is-the-true-cost-of-these-price-cuts-and-why-is-it-hidden 2022-08-23T13:00:01+10:00 https://pharmadispatch.com/news/sanofi-announces-industry-leading-gender-affirmation-policy 2022-08-23T13:00:01+10:00 https://pharmadispatch.com/news/gilead-sciences-launches-it-inaugural-reflect-reconciliation-act 2022-08-24T13:00:01+10:00 https://pharmadispatch.com/news/october-increases-in-the-midst-of-a-fierce-price-war 2022-08-24T13:00:01+10:00 https://pharmadispatch.com/news/a-change-that-must-be-the-worst-in-the-history-of-this-program 2022-08-24T11:54:01+10:00 https://pharmadispatch.com/news/medibank-extends-premium-increase-deferral-by-another-month 2022-08-25T06:46:01+10:00 https://pharmadispatch.com/news/nib-reports-strong-topline-growth-across-operations 2022-08-25T06:51:01+10:00 https://pharmadispatch.com/news/ramsay-health-care-and-bupa-sign-new-agreement 2022-08-25T06:56:01+10:00 https://pharmadispatch.com/news/choroid-plexus-tissue-shipped-to-sydney-as-ntcell-research-advan 2022-08-25T07:03:01+10:00 https://pharmadispatch.com/news/long-covid-19-study-identifies-novel-blood-markers-as-potential- 2022-08-25T07:08:01+10:00 https://pharmadispatch.com/news/dimerix-confirms-clarity-20-covid-19-study-concludes-recruitment 2022-08-25T07:10:01+10:00 https://pharmadispatch.com/news/quarterly-update-reignites-debate-over-medical-device-pricing 2022-08-25T09:30:01+10:00 https://pharmadispatch.com/news/hospitals-call-for-action-on-workforce-to-resolve-missing-admiss 2022-08-25T09:31:01+10:00 https://pharmadispatch.com/news/moderna-secures-the-services-of-former-government-adviser 2022-08-25T11:00:01+10:00 https://pharmadispatch.com/news/new-report-identifies-key-pandemic-trends-for-community-pharmacy 2022-08-25T09:58:01+10:00 https://pharmadispatch.com/news/viatris-monica-passfield-on-why-csr-is-fundamental-to-the-compan 2022-08-25T10:31:01+10:00 https://pharmadispatch.com/news/no-part-of-the-sector-will-escape-the-impact-of-these-structural 2022-08-26T11:00:01+10:00 https://pharmadispatch.com/news/more-power-in-the-hands-of-officials-means-the-time-has-come-for 2022-08-26T11:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-backs-move-to-manage-supply-of-heart-medici 2022-08-26T09:22:01+10:00 https://pharmadispatch.com/news/new-patient-survey-delivers-significant-boost-to-industry-reputa 2022-08-26T11:00:01+10:00 https://pharmadispatch.com/news/novartis-to-spin-off-generics-and-biosimilars-division 2022-08-26T14:00:01+10:00 https://pharmadispatch.com/news/two-australian-organisations-secures-majors-grants-from-gilead 2022-08-29T11:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-a-third-covid-19-treatment-for-listing-on-the-p 2022-08-29T11:00:01+10:00 https://pharmadispatch.com/news/is-mark-butler-moving-to-take-the-politics-out-of-the-pbs 2022-08-29T11:00:01+10:00 https://pharmadispatch.com/news/biomarins-kathryn-evans-uses-new-book-to-call-for-action-on-gend 2022-08-29T11:00:01+10:00 https://pharmadispatch.com/news/mark-butler-sticks-with-decision-to-defund-nps-medicinewise 2022-08-30T11:00:01+10:00 https://pharmadispatch.com/news/what-does-decision-to-walk-away-from-strategic-asset-mean-for-nm 2022-08-30T11:00:01+10:00 https://pharmadispatch.com/news/pharmacy-administers-almost-one-quarter-of-all-flu-vaccines 2022-08-30T11:00:01+10:00 https://pharmadispatch.com/news/monash-university-ai-model-could-predict-the-best-epilepsy-medic 2022-08-30T15:45:01+10:00 https://pharmadispatch.com/news/university-of-sydney-announces-landmark-investment-to-create-bio 2022-08-30T15:51:01+10:00 https://pharmadispatch.com/news/optiscan-imaging-submits-510k-application-to-the-us-fda 2022-08-31T08:29:01+10:00 https://pharmadispatch.com/news/emvision-medical-confirms-manufacturing-grant-will-proceed 2022-08-31T08:31:01+10:00 https://pharmadispatch.com/news/moderna-aims-to-supply-bivalent-covid-19-vaccine-in-september 2022-08-31T09:04:01+10:00 https://pharmadispatch.com/news/gsk-looking-to-build-with-major-recruitment-drive 2022-08-31T11:00:01+10:00 https://pharmadispatch.com/news/pharmac-acknowledges-stock-issues-in-message-to-suppliers 2022-08-31T11:00:01+10:00 https://pharmadispatch.com/news/recently-listed-insulins-also-on-the-list-for-major-catch-up-cut 2022-08-31T10:30:01+10:00 https://pharmadispatch.com/news/racgp-welcomes-urgent-care-partnership-between-victoria-and-nsw 2022-08-31T11:25:01+10:00 https://pharmadispatch.com/news/cynata-therapeutics-appoints-new-non-executive-director 2022-08-31T11:36:01+10:00 https://pharmadispatch.com/news/starpharma-wins-recognition-for-development-of-covid-19-antivira 2022-08-31T11:37:01+10:00 https://pharmadispatch.com/news/rebranded-acurabio-acquired-by-major-investors 2022-08-31T11:39:01+10:00 https://pharmadispatch.com/news/major-new-listing-for-people-living-with-chronic-kidney-disease 2022-09-01T10:55:01+10:00 https://pharmadispatch.com/news/antengene-welcomes-the-listing-of-its-first-medicine-on-the-pbs 2022-09-01T11:31:01+10:00 https://pharmadispatch.com/news/sanofis-with-vaccines-community-grants-awarded-to-eight-organisa 2022-09-01T11:43:01+10:00 https://pharmadispatch.com/news/gsks-official-return-to-oncology-with-listing-of-ovarian-cancer- 2022-09-01T12:25:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-new-pbs-listings 2022-09-01T16:00:01+10:00 https://pharmadispatch.com/news/leukaemia-foundation-launches-dedicated-blood-cancer-support-lin 2022-09-01T16:08:01+10:00 https://pharmadispatch.com/news/private-hospitals-slam-victorias-move-on-nursing-workforce 2022-09-01T16:23:01+10:00 https://pharmadispatch.com/news/clinuvel-reports-sixth-consecutive-annual-profit 2022-09-01T16:32:01+10:00 https://pharmadispatch.com/news/surely-the-best-patient-view-is-one-that-is-fully-informed 2022-09-02T11:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-secures-funding-from-leading-uk-organisation 2022-09-02T10:24:01+10:00 https://pharmadispatch.com/news/new-national-survey-reveals-more-on-australias-use-of-medicines 2022-09-02T11:00:01+10:00 https://pharmadispatch.com/news/reviews-have-been-an-almost-endless-feature-of-australias-use-of 2022-09-05T13:00:01+10:00 https://pharmadispatch.com/news/elevating-the-discussion-is-the-pre-condition-to-achieving-real- 2022-09-05T13:00:01+10:00 https://pharmadispatch.com/news/patient-group-welcomes-new-treatment-but-wants-action-on-newborn 2022-09-05T13:00:01+10:00 https://pharmadispatch.com/news/australia-becomes-one-of-the-first-to-fund-new-sanofi-therapy 2022-09-05T13:00:01+10:00 https://pharmadispatch.com/news/independence-takes-many-forms-and-it-can-be-over-rated 2022-09-06T13:00:01+10:00 https://pharmadispatch.com/news/chemotherapy-review-calls-for-major-reform-in-interim-report 2022-09-05T21:13:01+10:00 https://pharmadispatch.com/news/confidentiality-protections-will-constrain-new-hta-international 2022-09-05T22:55:01+10:00 https://pharmadispatch.com/news/medibank-research-reveals-pandemic-impact-on-workplace-confidenc 2022-09-06T00:09:01+10:00 https://pharmadispatch.com/news/new-parliamentary-inquiry-to-look-at-the-impact-of-long-covid 2022-09-06T00:11:01+10:00 https://pharmadispatch.com/news/hcf-announces-the-return-of-more-pandemic-related-savings 2022-09-06T00:12:01+10:00 https://pharmadispatch.com/news/bupa-backs-the-return-of-sustainable-september-in-melbourne 2022-09-06T00:15:01+10:00 https://pharmadispatch.com/news/prospection-announces-new-data-access-agreement-for-japan 2022-09-06T01:12:01+10:00 https://pharmadispatch.com/news/occurx-secures-funding-to-progress-potential-inflammation-and-fi 2022-09-06T21:08:01+10:00 https://pharmadispatch.com/news/esfam-biotech-receives-1-million-for-covid-19-treatment-discover 2022-09-06T21:10:01+10:00 https://pharmadispatch.com/news/qimr-berghofer-grants-option-and-license-agreement-for-potential 2022-09-06T21:11:01+10:00 https://pharmadispatch.com/news/recce-pharmaceuticals-announces-appointment-of-executive-chairma 2022-09-06T21:13:01+10:00 https://pharmadispatch.com/news/immutep-signs-agreement-for-new-phase-2-efti-trial 2022-09-06T21:14:01+10:00 https://pharmadispatch.com/news/report-calls-for-more-consideration-of-societal-benefits-in-hta- 2022-09-07T13:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-would-it-actually-make-a-difference-to-decision-makin 2022-09-07T01:07:01+10:00 https://pharmadispatch.com/news/pharmac-delivers-minimal-action-in-interim-response-to-scathing- 2022-09-07T13:00:01+10:00 https://pharmadispatch.com/news/merck-team-gets-behind-jean-hailes-womens-health-week 2022-09-07T13:00:01+10:00 https://pharmadispatch.com/news/merger-combines-doctor-patient-software-management-platforms 2022-09-08T13:00:01+10:00 https://pharmadispatch.com/news/government-introduces-legislation-to-cut-general-pbs-co-payment 2022-09-08T13:00:01+10:00 https://pharmadispatch.com/news/new-molecule-chip-changing-the-face-of-modern-manufacturing 2022-09-07T20:13:01+10:00 https://pharmadispatch.com/news/watch-for-the-impact-of-blue-light-devices-on-eyes-and-sleep-pat 2022-09-07T21:21:01+10:00 https://pharmadispatch.com/news/mixed-emotions-for-companies-carrying-the-cost-of-co-pay-reducti 2022-09-08T13:00:01+10:00 https://pharmadispatch.com/news/the-pbs-pricing-framework-has-produced-a-confusing-time-for-bios 2022-09-08T13:00:01+10:00 https://pharmadispatch.com/news/medibank-in-new-partnership-to-create-orthopaedic-surgical-centr 2022-09-08T18:26:01+10:00 https://pharmadispatch.com/news/watch-for-the-impact-of-blue-light-devices-on-eyes-and-sleep-pat 2022-09-08T18:30:01+10:00 https://pharmadispatch.com/news/victoria-backs-new-andhealth-created-innovation-and-commercialis 2022-09-08T18:32:01+10:00 https://pharmadispatch.com/news/antisense-therapeutics-announces-revised-clinical-development-pl 2022-09-08T20:44:01+10:00 https://pharmadispatch.com/news/imugene-doses-first-patient-in-nextherizon-phase-2-clinical-tria 2022-09-08T20:46:01+10:00 https://pharmadispatch.com/news/the-first-set-of-discretion-outcomes-deliver-as-expected 2022-09-09T13:00:01+10:00 https://pharmadispatch.com/news/the-power-is-described-as-ministerial-but-it-will-be-exercised-b 2022-09-09T13:00:01+10:00 https://pharmadispatch.com/news/msd-looking-to-pbs-for-another-new-keytruda-indication 2022-09-09T13:00:01+10:00 https://pharmadispatch.com/news/starting-in-the-right-place-means-an-honest-assessment-of-the-ri 2022-09-12T13:00:01+10:00 https://pharmadispatch.com/news/secretly-negotiated-collaboration-pre-empts-agreement-outcome 2022-09-12T13:00:01+10:00 https://pharmadispatch.com/news/janssen-appoints-new-managing-director-to-succeed-biljananaumovi 2022-09-12T13:00:01+10:00 https://pharmadispatch.com/news/racgp-welcomes-major-contract-to-deliver-gp-training-in-australi 2022-09-12T20:27:01+10:00 https://pharmadispatch.com/news/hbf-reports-significant-member-growth-in-challenging-economic-en 2022-09-12T20:56:01+10:00 https://pharmadispatch.com/news/antisense-therapeutics-says-dosing-has-commenced-in-combination- 2022-09-12T21:12:01+10:00 https://pharmadispatch.com/news/us-fda-grants-orphan-designation-for-radiopharm-theranostics-dun 2022-09-12T21:36:01+10:00 https://pharmadispatch.com/news/new-national-president-to-lead-college-of-general-practitioners 2022-09-12T23:32:01+10:00 https://pharmadispatch.com/news/pharmac-extends-access-criteria-to-covid-19-antiviral-treatments 2022-09-13T13:00:01+10:00 https://pharmadispatch.com/news/document-reveals-valuable-insights-on-impact-of-pricing-reforms 2022-09-13T13:00:01+10:00 https://pharmadispatch.com/news/health-minister-accepts-advice-on-adding-bivalent-vaccine-to-nat 2022-09-13T13:00:01+10:00 https://pharmadispatch.com/news/botanix-completes-issue-of-first-tranche-of-major-placement 2022-09-13T18:15:01+10:00 https://pharmadispatch.com/news/clarity-strengthens-protection-of-sar-bispsma-product-with-china 2022-09-13T18:17:01+10:00 https://pharmadispatch.com/news/private-equity-terminates-proposed-acquisition-of-ramsay-health- 2022-09-13T19:51:01+10:00 https://pharmadispatch.com/news/asia-pacific-takes-the-lead-on-new-gene-and-cell-therapy-trials 2022-09-14T12:00:01+10:00 https://pharmadispatch.com/news/ma-chair-labels-implementation-disingenuous-and-a-breach-of-new- 2022-09-14T00:17:01+10:00 https://pharmadispatch.com/news/not-too-late-to-gain-a-proper-understanding-of-what-is-really-in 2022-09-14T13:00:01+10:00 https://pharmadispatch.com/news/new-research-identifies-link-between-covid-19-and-atrial-fibrill 2022-09-14T02:49:01+10:00 https://pharmadispatch.com/news/nps-medicinewise-announces-plan-to-cease-operations-in-response- 2022-09-14T03:01:01+10:00 https://pharmadispatch.com/news/former-gsk-executive-to-lead-csls-reputation-management-centre 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/he-was-respected-liked-and-just-a-thoroughly-decent-person-who-w 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/antengene-follows-first-pbs-listing-with-the-opening-of-new-offi 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/black-dog-institute-welcomes-tga-consultation-on-paracetamol 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/moderna-continues-to-build-executive-team-with-latest-appointmen 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/bupa-customers-to-receive-315-million-in-pre-christmas-cashback 2022-09-14T23:04:01+10:00 https://pharmadispatch.com/news/medibanks-live-better-program-hits-500000-members 2022-09-14T23:05:01+10:00 https://pharmadispatch.com/news/new-blood-cancer-research-urges-national-reform-for-regions 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/noxopharm-reports-promising-results-from-pancreatic-cancer-study 2022-09-14T23:51:01+10:00 https://pharmadispatch.com/news/immutep-provides-clinical-update-on-efti-and-confirms-board-appo 2022-09-14T23:53:01+10:00 https://pharmadispatch.com/news/bit225-confirms-start-of-new-covid-19-human-study 2022-09-14T23:54:01+10:00 https://pharmadispatch.com/news/epiaxis-therapeutics-announces-collaboration-with-canadian-resea 2022-09-14T23:54:01+10:00 https://pharmadispatch.com/news/sanofi-confirms-the-appointment-of-head-of-corporate-affairs 2022-09-15T13:00:01+10:00 https://pharmadispatch.com/news/ucb-australia-recognised-in-the-australian-business-awards 2022-09-16T13:00:01+10:00 https://pharmadispatch.com/news/new-zealand-patients-implore-pharmac-to-fund-blood-cancer-therap 2022-09-16T13:00:01+10:00 https://pharmadispatch.com/news/review-identified-major-holes-in-nps-medicinewise-defunding-deci 2022-09-16T13:00:01+10:00 https://pharmadispatch.com/news/did-anyone-actually-read-this-report-before-confirming-the-decis 2022-09-16T13:00:01+10:00 https://pharmadispatch.com/news/the-choice-is-to-be-more-defensive-or-continue-to-suffer-bad-out 2022-09-19T13:00:01+10:00 https://pharmadispatch.com/news/industry-prepares-to-put-forward-its-evidence-for-agreement-brea 2022-09-19T13:00:01+10:00 https://pharmadispatch.com/news/department-moving-to-tax-the-medical-device-sector-with-new-levy 2022-09-18T18:51:01+10:00 https://pharmadispatch.com/news/bayers-ashraf-al-ouf-elevated-to-chair-the-company-across-austra 2022-09-19T13:00:01+10:00 https://pharmadispatch.com/news/federal-government-extends-covid-19-response-measures 2022-09-19T19:27:01+10:00 https://pharmadispatch.com/news/fda-grants-important-designation-to-radiopharm-theranostics-dunp 2022-09-19T19:47:01+10:00 https://pharmadispatch.com/news/medibank-commits-to-accelerate-plan-to-achieve-net-zero 2022-09-19T20:07:01+10:00 https://pharmadispatch.com/news/major-milestone-for-polynovo-for-fda-clearance-of-wound-care-inn 2022-09-19T21:28:01+10:00 https://pharmadispatch.com/news/medibio-appoints-experienced-medical-executive-as-new-ceo 2022-09-19T23:53:01+10:00 https://pharmadispatch.com/news/farewelling-a-legend-and-understanding-the-reality-of-policy 2022-09-20T13:00:01+10:00 https://pharmadispatch.com/news/the-industrys-argument-will-succeed-or-fail-based-on-the-legal-i 2022-09-21T13:00:01+10:00 https://pharmadispatch.com/news/industry-says-discussion-forthright-but-department-defends-imple 2022-09-21T13:00:01+10:00 https://pharmadispatch.com/news/csl-seqirus-specialist-recognised-at-women-in-industry-awards 2022-09-21T13:00:01+10:00 https://pharmadispatch.com/news/noxopharm-founder-to-depart-board-as-part-of-natural-evolution 2022-09-21T00:38:01+10:00 https://pharmadispatch.com/news/stockholding-commitment-included-on-the-list-of-industry-concern 2022-09-22T19:11:01+10:00 https://pharmadispatch.com/news/provisional-approval-for-pfizer-covid-19-vaccine-as-a-booster-in 2022-09-23T13:00:01+10:00 https://pharmadispatch.com/news/novavax-leader-hopeful-australia-will-move-ahead-on-boosters 2022-09-22T20:31:01+10:00 https://pharmadispatch.com/news/pharmac-launches-consultation-process-on-provisional-bundle-deal 2022-09-23T13:00:01+10:00 https://pharmadispatch.com/news/the-very-real-and-even-likely-scenario-facing-some-companies 2022-09-26T13:00:01+10:00 https://pharmadispatch.com/news/next-aprils-catch-up-reduction-day-will-be-followed-by-annual-mo 2022-09-26T13:00:01+10:00 https://pharmadispatch.com/news/do-the-industrys-agreements-make-the-pivot-to-price-defence-advo 2022-09-26T13:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-encourages-stakeholder-input-on-revised-poli 2022-09-26T13:00:01+10:00 https://pharmadispatch.com/news/new-survey-reveals-australians-want-pharmacists-to-do-more 2022-09-25T19:35:01+10:00 https://pharmadispatch.com/news/does-mark-butler-want-the-industry-take-some-responsibility 2022-09-28T13:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-releases-promising-interim-data-from-skin-scarring-stu 2022-09-27T13:00:01+10:00 https://pharmadispatch.com/news/new-listings-for-october-but-mixed-outcomes-for-patients-on-out- 2022-09-27T13:00:01+10:00 https://pharmadispatch.com/news/australian-expatriate-leading-novartis-global-cardiovascular-fra 2022-09-27T13:00:01+10:00 https://pharmadispatch.com/news/new-leadership-coming-for-bristol-myers-squibb-australia 2022-09-27T13:00:01+10:00 https://pharmadispatch.com/news/grant-go-support-cardiovascular-study-of-cynata-therapeutics-cel 2022-09-27T01:53:01+10:00 https://pharmadispatch.com/news/emyria-advances-phase-3-trial-of-cannabinoid-treatment 2022-09-27T01:57:01+10:00 https://pharmadispatch.com/news/alterity-therapeutics-announces-poster-presentation-from-major-s 2022-09-27T01:59:01+10:00 https://pharmadispatch.com/news/botanix-pharmaceuticals-submits-new-drug-application-to-fda 2022-09-27T02:00:01+10:00 https://pharmadispatch.com/news/halton-review-recommends-more-forward-thinking-on-emergencies 2022-09-28T00:11:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-funding-for-long-acting-growth-hormone-treatment 2022-09-28T00:51:01+10:00 https://pharmadispatch.com/news/vertex-australian-joins-global-colleagues-in-day-of-service 2022-09-28T15:13:01+10:00 https://pharmadispatch.com/news/csl-announces-seven-recipients-of-global-research-acceleration-i 2022-09-28T15:35:01+10:00 https://pharmadispatch.com/news/biogen-and-eisai-announce-major-milestone-for-potential-alzheime 2022-09-28T20:12:01+10:00 https://pharmadispatch.com/news/pharmac-consulting-on-new-funding-proposals-including-sma-therap 2022-09-28T21:03:01+10:00 https://pharmadispatch.com/news/major-new-collaboration-launches-cv-screening-pilot-with-nationa 2022-09-28T21:58:01+10:00 https://pharmadispatch.com/news/final-outcome-reveals-lower-than-forecast-spending-on-pharmaceut 2022-09-28T22:05:01+10:00 https://pharmadispatch.com/news/more-speakers-confirmed-for-bpd-post-budget-summit 2022-09-29T13:00:01+10:00 https://pharmadispatch.com/news/mps-speak-out-in-support-of-defunded-nps-medicinewise 2022-09-29T13:00:01+10:00 https://pharmadispatch.com/news/agilex-biolabs-expands-capacity-with-the-commissioning-of-new-br 2022-09-29T03:31:01+10:00 https://pharmadispatch.com/news/new-high-court-justice-a-major-figure-in-pharmas-legal-history 2022-09-30T13:00:01+10:00 https://pharmadispatch.com/news/new-anti-corruption-body-has-real-implications-for-hta-decision- 2022-09-29T21:11:01+10:00 https://pharmadispatch.com/news/tga-provisionally-approves-pfizers-covid-19-vaccine-for-younger- 2022-09-30T14:00:01+10:00 https://pharmadispatch.com/news/ipsen-welcomes-first-and-only-pbs-listing-for-ultra-rare-short-s 2022-09-30T13:00:01+10:00 https://pharmadispatch.com/news/new-blood-cancer-listing-means-the-financial-weight-is-lifted 2022-09-30T13:00:01+10:00 https://pharmadispatch.com/news/introducing-the-first-week-in-review-episode-of-the-dispatched-p 2022-09-30T22:55:01+10:00 https://pharmadispatch.com/news/this-association-needs-to-add-the-set-of-skills-it-does-not-have 2022-10-04T14:00:01+11:00 https://pharmadispatch.com/news/wait-for-indicative-discretion-outcomes-down-to-less-than-a-week 2022-10-04T14:00:01+11:00 https://pharmadispatch.com/news/bms-welcomes-expanded-pbs-listing-for-key-immunotherapy 2022-10-04T00:08:01+11:00 https://pharmadispatch.com/news/australian-company-doses-first-patient-in-mnd-clinical-trial 2022-10-04T00:37:01+11:00 https://pharmadispatch.com/news/tga-provisional-determination-for-modernas-covid-19-bivalent-boo 2022-10-04T00:44:01+11:00 https://pharmadispatch.com/news/private-health-insurers-call-for-reform-of-second-tier-default-b 2022-10-04T03:03:01+11:00 https://pharmadispatch.com/news/dietitians-australia-calls-for-action-on-aged-care-weight-loss 2022-10-04T03:05:01+11:00 https://pharmadispatch.com/news/hbf-run-for-a-reason-is-back-after-three-year-hiatus 2022-10-04T03:06:01+11:00 https://pharmadispatch.com/news/nature-publishes-data-on-dunp19-receptors-role-in-cancer-growth 2022-10-04T23:50:01+11:00 https://pharmadispatch.com/news/australian-biotechnology-incubator-proto-axiom-completes-initial 2022-10-04T23:52:01+11:00 https://pharmadispatch.com/news/latest-statistical-update-shows-cancer-survival-rates-continue-t 2022-10-05T00:35:01+11:00 https://pharmadispatch.com/news/the-red-flags-are-flying-on-more-cost-recovery-changes 2022-10-06T14:00:01+11:00 https://pharmadispatch.com/news/ma-deputy-chair-departs-after-promotion-to-senior-role-in-europe 2022-10-05T14:00:01+11:00 https://pharmadispatch.com/news/former-medicines-australia-executive-joins-ministers-office 2022-10-05T14:00:01+11:00 https://pharmadispatch.com/news/two-australian-organisations-to-share-roche-125-year-anniversary 2022-10-05T14:00:01+11:00 https://pharmadispatch.com/news/list-published-of-the-over-2900-pbs-items-designated-for-stock-c 2022-10-05T03:35:01+11:00 https://pharmadispatch.com/news/second-fast-track-designation-for-australian-immunotherapy-compa 2022-10-06T14:00:01+11:00 https://pharmadispatch.com/news/novavax-welcomes-the-recommendations-of-halton-review 2022-10-06T14:00:01+11:00 https://pharmadispatch.com/news/medicines-australia-confirms-it-has-presented-the-evidence-to-mi 2022-10-06T14:00:01+11:00 https://pharmadispatch.com/news/atmo-announces-publication-of-positive-gas-capsule-clinical-tria 2022-10-05T22:54:01+11:00 https://pharmadispatch.com/news/perth-hospital-becomes-the-first-in-state-to-use-new-robotic-sur 2022-10-05T23:08:01+11:00 https://pharmadispatch.com/news/illumina-unveils-novaseq-x-series-to-accelerate-genomic-discover 2022-10-06T01:46:01+11:00 https://pharmadispatch.com/news/if-patient-access-will-be-the-victim-then-this-debate-needs-to-b 2022-10-07T14:00:01+11:00 https://pharmadispatch.com/news/submission-to-treasury-review-calls-for-an-end-to-favourable-tax 2022-10-07T14:00:01+11:00 https://pharmadispatch.com/news/is-this-another-assault-on-special-pricing-arrangements 2022-10-07T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-7-october 2022-10-07T22:54:01+11:00 https://pharmadispatch.com/news/biontech-chooses-melbourne-for-asia-pacific-mrna-rd-centre 2022-10-10T14:00:01+11:00 https://pharmadispatch.com/news/csl-seqirus-secures-us-government-agreement-to-develop-vaccine-c 2022-10-10T14:00:01+11:00 https://pharmadispatch.com/news/the-industrys-much-anticipated-day-of-discretion-finally-arrives 2022-10-10T14:00:01+11:00 https://pharmadispatch.com/news/the-industry-dismissed-the-risk-of-double-dipping-last-year 2022-10-10T14:00:01+11:00 https://pharmadispatch.com/news/can-the-industry-learn-that-secrecy-and-avoiding-scrutiny-lead-t 2022-10-10T14:00:01+11:00 https://pharmadispatch.com/news/platform-launched-for-aboriginal-and-torres-strait-islander-peop 2022-10-10T22:47:01+11:00 https://pharmadispatch.com/news/construction-starts-on-new-hospital-driven-by-medibank-joint-ven 2022-10-10T22:50:01+11:00 https://pharmadispatch.com/news/racgp-backs-call-to-cut-the-red-tape-holding-back-foreign-doctor 2022-10-10T22:52:01+11:00 https://pharmadispatch.com/news/major-appointments-and-rebrand-for-australian-medicinal-cannabis 2022-10-11T14:00:01+11:00 https://pharmadispatch.com/news/an-eerie-silence-broken-by-late-notice-of-delay-in-indicative-ou 2022-10-11T14:00:01+11:00 https://pharmadispatch.com/news/pharma-australia-inclusion-group-launches-program-and-welcomes-n 2022-10-11T04:16:01+11:00 https://pharmadispatch.com/news/these-issues-and-the-process-are-evidence-of-system-under-signif 2022-10-11T21:49:01+11:00 https://pharmadispatch.com/news/outcomes-start-coming-with-companies-describing-them-as-a-mixed- 2022-10-12T14:00:01+11:00 https://pharmadispatch.com/news/australian-company-taps-well-known-former-government-official-fo 2022-10-12T14:00:01+11:00 https://pharmadispatch.com/news/pfizer-and-gilead-team-up-on-lgbtq-inclusion-for-the-industry 2022-10-12T14:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-lilly-with-promotion-for-benjamin-basil 2022-10-12T02:30:01+11:00 https://pharmadispatch.com/news/major-change-for-leading-patient-advocate-with-move-to-emerging- 2022-10-13T14:00:01+11:00 https://pharmadispatch.com/news/us-based-bio-looking-for-new-leadership-after-challenging-period 2022-10-13T14:00:01+11:00 https://pharmadispatch.com/news/federal-government-to-set-gender-targets-for-major-nhmrc-researc 2022-10-12T22:21:01+11:00 https://pharmadispatch.com/news/illumina-and-astrazeneca-team-up-on-ai-based-research-project 2022-10-13T14:00:01+11:00 https://pharmadispatch.com/news/viiv-healthcare-launches-2022-community-grants-programs 2022-10-13T14:00:01+11:00 https://pharmadispatch.com/news/outcomes-just-confirm-the-truly-dreadful-and-damaging-nature-of- 2022-10-14T14:00:01+11:00 https://pharmadispatch.com/news/indicative-outcomes-clearly-driven-by-need-to-deliver-budgeted-s 2022-10-14T14:00:01+11:00 https://pharmadispatch.com/news/is-the-department-assessing-its-own-application-for-discretion 2022-10-14T14:00:01+11:00 https://pharmadispatch.com/news/pharma-inclusion-group-launches-report-on-future-of-workplace-in 2022-10-14T14:00:01+11:00 https://pharmadispatch.com/news/committee-recommends-the-narrowest-of-lung-cancer-screening-prog 2022-10-14T14:00:01+11:00 https://pharmadispatch.com/news/cartherics-opens-new-melbourne-based-lab-to-develop-cancer-immun 2022-10-14T03:06:01+11:00 https://pharmadispatch.com/news/the-week-in-review-14-october 2022-10-14T22:53:01+11:00 https://pharmadispatch.com/news/csl-awards-two-five-year-fellowships-to-australian-researchers 2022-10-17T14:00:01+11:00 https://pharmadispatch.com/news/sanofi-doubles-commitment-to-solar-with-3000-panels-at-manufactu 2022-10-17T14:00:01+11:00 https://pharmadispatch.com/news/federal-government-announces-detailed-agenda-for-reform-of-the-p 2022-10-17T14:00:01+11:00 https://pharmadispatch.com/news/evusheld-outcome-highlights-the-challenge-of-consistent-and-equi 2022-10-17T14:00:01+11:00 https://pharmadispatch.com/news/september-meeting-delivers-mixed-outcomes-for-covid-19-therapies 2022-10-17T14:00:01+11:00 https://pharmadispatch.com/news/andhealth-ceo-recognised-with-the-telstra-brilliant-women-in-dig 2022-10-17T04:41:01+11:00 https://pharmadispatch.com/news/microbiogen-opens-state-of-the-art-laboratory-facilities-in-sydn 2022-10-17T04:42:01+11:00 https://pharmadispatch.com/news/new-treatment-guidelines-unveiled-for-first-nations-people-livin 2022-10-17T04:44:01+11:00 https://pharmadispatch.com/news/novartis-makes-list-of-australias-most-innovative-health-compani 2022-10-17T14:00:01+11:00 https://pharmadispatch.com/news/bupa-launches-its-new-rewards-and-loyalty-program-life-rewards 2022-10-17T05:38:01+11:00 https://pharmadispatch.com/news/medibank-continues-to-update-on-recent-cybersecurity-incident 2022-10-17T06:02:01+11:00 https://pharmadispatch.com/news/nib-announce-capital-raise-and-entry-into-the-ndis-sector 2022-10-17T06:08:01+11:00 https://pharmadispatch.com/news/csl-updates-on-its-strategic-integration-of-vifor-pharma 2022-10-18T14:00:01+11:00 https://pharmadispatch.com/news/pharmacy-expanded-scope-of-practice-pilot-set-to-get-underway 2022-10-18T14:00:01+11:00 https://pharmadispatch.com/news/pharmac-updates-on-the-125-therapies-currently-on-its-option-for 2022-10-18T14:00:01+11:00 https://pharmadispatch.com/news/servier-commissioned-survey-reveals-many-gps-overlooking-their-o 2022-10-18T14:00:01+11:00 https://pharmadispatch.com/news/wholesalers-activate-plans-to-deliver-medicine-to-flood-affected 2022-10-18T14:00:01+11:00 https://pharmadispatch.com/news/auditor-general-yet-to-make-a-decision-on-audit-of-pbs-administr 2022-10-19T14:00:01+11:00 https://pharmadispatch.com/news/committee-is-now-recommending-that-companies-engage-in-price-fix 2022-10-18T22:43:01+11:00 https://pharmadispatch.com/news/we-can-only-hope-this-outcome-is-a-thought-bubble-that-will-be-i 2022-10-19T14:00:01+11:00 https://pharmadispatch.com/news/new-campaign-aims-to-raise-awareness-of-invasive-meningococcal-d 2022-10-19T14:00:01+11:00 https://pharmadispatch.com/news/radiopharm-theranostics-announces-positive-data-from-brain-cance 2022-10-19T20:37:01+11:00 https://pharmadispatch.com/news/pharmaxis-reports-positive-interim-data-from-myelofibrosis-study 2022-10-20T14:00:01+11:00 https://pharmadispatch.com/news/first-of-its-kind-study-to-explore-cancer-from-a-first-nations-p 2022-10-19T21:11:01+11:00 https://pharmadispatch.com/news/viatris-the-top-ranked-healthcare-company-in-best-workplaces-to- 2022-10-20T14:00:01+11:00 https://pharmadispatch.com/news/new-study-confirms-rhinoswab-as-preferred-method-for-testing-chi 2022-10-20T00:00:01+11:00 https://pharmadispatch.com/news/msd-australia-helps-shine-a-light-on-the-265-million-australians 2022-10-20T14:00:01+11:00 https://pharmadispatch.com/news/better-access-australia-calls-for-senate-action-on-co-payment-in 2022-10-20T14:00:01+11:00 https://pharmadispatch.com/news/report-says-australia-can-be-a-global-destination-for-digital-he 2022-10-20T02:04:01+11:00 https://pharmadispatch.com/news/hbf-confirms-the-appointment-of-its-new-ceo 2022-10-20T03:13:01+11:00 https://pharmadispatch.com/news/medibank-enters-trading-halt-in-response-to-contact-from-potenti 2022-10-20T04:56:01+11:00 https://pharmadispatch.com/news/another-day-and-another-change-that-only-aims-to-further-exclude 2022-10-21T14:00:01+11:00 https://pharmadispatch.com/news/independent-report-delivers-scathing-assessment-of-covid-19-vacc 2022-10-21T14:00:01+11:00 https://pharmadispatch.com/news/australian-company-secures-significant-milestone-payment-with-fd 2022-10-20T23:54:01+11:00 https://pharmadispatch.com/news/gedeon-richter-joins-generic-and-biosimilar-medicines-associatio 2022-10-21T14:00:01+11:00 https://pharmadispatch.com/news/tga-grants-new-provisional-approval-for-moderna-covid-19-vaccine 2022-10-21T00:56:01+11:00 https://pharmadispatch.com/news/the-week-in-review-21-october 2022-10-21T23:50:01+11:00 https://pharmadispatch.com/news/new-listings-but-will-it-be-smooth-sailing-in-the-senate-for-co- 2022-10-24T14:00:01+11:00 https://pharmadispatch.com/news/summit-to-focus-on-budget-agreements-system-level-change-and-tax 2022-10-24T14:00:01+11:00 https://pharmadispatch.com/news/further-pricing-reform-put-front-and-centre-of-us-mid-term-elect 2022-10-24T14:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-budget-week-review 2022-10-24T04:10:01+11:00 https://pharmadispatch.com/news/university-of-sydney-led-research-consortium-manufactures-living 2022-10-24T19:59:01+11:00 https://pharmadispatch.com/news/aculeus-therapeutics-reaches-major-milestone-with-launch-of-stud 2022-10-24T20:07:01+11:00 https://pharmadispatch.com/news/first-satellite-bioanalytical-lab-offers-fastest-option-for-pbmc 2022-10-24T21:45:01+11:00 https://pharmadispatch.com/news/sanofi-backs-bleeding-disorders-awareness-month-with-virtual-eve 2022-10-25T14:00:01+11:00 https://pharmadispatch.com/news/timely-reminder-of-why-this-program-urgently-needs-transparency- 2022-10-25T14:00:01+11:00 https://pharmadispatch.com/news/consumers-health-forum-confirms-interim-leader-as-new-ceo 2022-10-25T14:00:01+11:00 https://pharmadispatch.com/news/nib-sets-pathway-to-net-zero-carbon-emissions-by-2040 2022-10-25T03:02:01+11:00 https://pharmadispatch.com/news/bupa-health-insurance-wins-recognition-in-annual-canstar-awards 2022-10-25T03:04:01+11:00 https://pharmadispatch.com/news/key-senator-considering-amendment-to-co-pay-reduction-legislatio 2022-10-25T14:00:01+11:00 https://pharmadispatch.com/news/companies-start-submitting-additional-information-in-support-of- 2022-10-25T14:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-confirms-new-leadership-for-australia-and-n 2022-10-25T21:00:01+11:00 https://pharmadispatch.com/news/cyber-theft-of-identifiable-personal-patient-information-a-wake- 2022-10-25T21:38:01+11:00 https://pharmadispatch.com/news/medical-technology-sector-welcomes-federal-grant-to-local-compan 2022-10-25T22:06:01+11:00 https://pharmadispatch.com/news/mark-butler-about-to-race-past-the-former-governments-nine-year- 2022-10-26T14:00:01+11:00 https://pharmadispatch.com/news/the-decline-in-spending-is-what-the-industry-negotiated-in-its-a 2022-10-26T14:00:01+11:00 https://pharmadispatch.com/news/dumping-the-funding-guarantee-brand-opens-the-door-to-an-honest- 2022-10-26T14:00:01+11:00 https://pharmadispatch.com/news/new-zealand-moves-to-widen-access-to-two-critical-vaccines 2022-10-27T14:00:01+11:00 https://pharmadispatch.com/news/senate-requires-legislative-instruments-for-all-section-100-spec 2022-10-27T14:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-signs-mou-with-us-based-medical-health-industry-assoc 2022-10-26T23:41:01+11:00 https://pharmadispatch.com/news/andhealth-and-launchvic-partner-on-new-digital-health-accelerato 2022-10-26T23:46:01+11:00 https://pharmadispatch.com/news/stakeholder-groups-not-giving-up-but-government-pushing-back-on- 2022-10-27T14:00:01+11:00 https://pharmadispatch.com/news/csl-secures-licence-agreement-for-potential-blood-clot-therapy 2022-10-27T14:00:01+11:00 https://pharmadispatch.com/news/power-asymmetry-is-the-biggest-issue-for-advocates-of-hta-reform 2022-10-28T14:00:01+11:00 https://pharmadispatch.com/news/john-young-expects-open-engagement-and-a-focus-on-what-patients- 2022-10-28T14:00:01+11:00 https://pharmadispatch.com/news/program-finalised-for-mondays-bpd-post-budget-summit 2022-10-28T06:25:01+11:00 https://pharmadispatch.com/news/pbs-rebates-rapidly-approaching-a-new-milestone 2022-10-28T22:07:01+11:00 https://pharmadispatch.com/news/the-week-in-review-28-october 2022-10-29T00:23:01+11:00 https://pharmadispatch.com/news/power-asymmetry-is-the-biggest-issue-for-advocates-of-hta-reform 2022-10-28T22:19:01+11:00 https://pharmadispatch.com/news/will-the-recent-period-of-growth-survive-the-latest-pricing-bomb 2022-10-31T14:00:01+11:00 https://pharmadispatch.com/news/when-did-reform-become-about-avoiding-the-bad-outcomes-it-create 2022-10-31T14:00:01+11:00 https://pharmadispatch.com/news/when-did-reform-become-about-avoiding-the-bad-outcomes-it-create 2022-10-31T13:00:01+11:00 https://pharmadispatch.com/news/sanofi-employees-contribute-800-hours-in-we-volunteer-month 2022-11-01T14:00:01+11:00 https://pharmadispatch.com/news/tpg-capital-asia-completes-investment-in-inova-pharmaceuticals 2022-11-01T14:00:01+11:00 https://pharmadispatch.com/news/roche-welcomes-new-lung-cancer-listing-for-immunotherapy 2022-11-01T14:00:01+11:00 https://pharmadispatch.com/news/australia-rises-in-global-rankings-of-early-and-mid-stage-clinic 2022-11-01T14:00:01+11:00 https://pharmadispatch.com/news/world-first-brain-cancer-clinical-trials-launched-in-melbourne 2022-11-01T20:42:01+11:00 https://pharmadispatch.com/news/orthocells-remplir-added-to-australias-prostheses-list 2022-11-01T21:08:01+11:00 https://pharmadispatch.com/news/australian-digital-health-agency-and-csiro-in-new-collaboration 2022-11-01T21:10:01+11:00 https://pharmadispatch.com/news/private-health-insurers-call-on-others-to-match-level-of-transpa 2022-11-01T21:19:01+11:00 https://pharmadispatch.com/news/medical-device-sector-wants-regulator-to-investigate-health-insu 2022-11-01T21:21:01+11:00 https://pharmadispatch.com/news/minister-says-nmp-review-an-important-opportunity-to-set-high-le 2022-11-02T14:00:01+11:00 https://pharmadispatch.com/news/anne-ruston-says-the-need-for-reform-has-been-heard-loud-and-cle 2022-11-02T14:00:01+11:00 https://pharmadispatch.com/news/these-are-the-opportunities-that-we-see-are-you-interested-in-ha 2022-11-02T02:00:01+11:00 https://pharmadispatch.com/news/merck-pulls-medicines-in-response-to-new-pbs-pricing-framework 2022-11-02T14:00:01+11:00 https://pharmadispatch.com/news/csl-secures-rights-to-late-stage-mrna-covid-19-vaccine 2022-11-03T14:00:01+11:00 https://pharmadispatch.com/news/new-chapter-is-the-opportunity-for-a-new-approach-and-a-do-no-ha 2022-11-04T14:00:01+11:00 https://pharmadispatch.com/news/major-generics-multinational-looking-to-expand-in-australia 2022-11-03T14:00:01+11:00 https://pharmadispatch.com/news/bms-the-2022-list-of-australias-best-workplaces-for-women 2022-11-03T14:00:01+11:00 https://pharmadispatch.com/news/new-trikafta-approval-as-pbac-considers-expanded-listing 2022-11-03T14:00:01+11:00 https://pharmadispatch.com/news/battle-continues-over-the-reform-of-medical-device-pricing 2022-11-03T21:10:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-mtpconnect-announced-board-changes 2022-11-04T14:00:01+11:00 https://pharmadispatch.com/news/four-new-directors-elected-to-the-medicines-australia-board 2022-11-04T03:34:01+11:00 https://pharmadispatch.com/news/clarity-around-the-principles-with-a-willingness-to-engage-and-s 2022-11-04T14:00:01+11:00 https://pharmadispatch.com/news/2022-list-of-australias-best-workplaces-for-women 2022-11-04T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-4-november 2022-11-04T21:59:01+11:00 https://pharmadispatch.com/news/department-of-health-says-no-to-the-release-of-information 2022-11-07T14:00:01+11:00 https://pharmadispatch.com/news/pfizer-abbvie-and-novartis-top-new-pharma-reputation-list 2022-11-07T14:00:01+11:00 https://pharmadispatch.com/news/mark-butler-launches-independent-review-of-medicare-integrity 2022-11-07T14:00:01+11:00 https://pharmadispatch.com/news/three-more-years-for-medicines-australia-chair 2022-11-07T14:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-celebrates-major-covid-19-vaccination-milestone 2022-11-07T00:28:01+11:00 https://pharmadispatch.com/news/medibank-says-it-will-not-pay-cyberattack-ransom 2022-11-07T20:42:01+11:00 https://pharmadispatch.com/news/telix-announces-positive-topline-results-of-late-stage-kidney-ca 2022-11-07T20:55:01+11:00 https://pharmadispatch.com/news/australian-study-provides-evidence-base-for-switching-ms-treatme 2022-11-08T14:00:01+11:00 https://pharmadispatch.com/news/cervical-cancer-foundation-wants-greater-awareness-and-action 2022-11-08T14:00:01+11:00 https://pharmadispatch.com/news/tinkering-with-technical-inputs-wont-achieve-the-change-people-w 2022-11-09T14:00:01+11:00 https://pharmadispatch.com/news/australian-biotech-welcomes-ground-breaking-results-from-researc 2022-11-08T14:00:01+11:00 https://pharmadispatch.com/news/bms-takes-another-step-forward-in-the-pursuit-of-clinical-trial- 2022-11-08T14:00:01+11:00 https://pharmadispatch.com/news/hbf-announces-planned-acquisition-regional-queensland-health-fun 2022-11-08T04:02:01+11:00 https://pharmadispatch.com/news/pharmac-to-widen-access-to-pfizers-pneumococcal-vaccine 2022-11-08T04:17:01+11:00 https://pharmadispatch.com/news/are-states-exercising-a-veto-power-on-national-hta-outcomes 2022-11-08T14:00:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-updates-on-multiple-system-atrophy-study 2022-11-08T20:23:01+11:00 https://pharmadispatch.com/news/uk-approval-for-artryas-salix-coronary-anatomy-product 2022-11-08T20:26:01+11:00 https://pharmadispatch.com/news/impacted-patients-give-their-verdict-on-the-new-pricing-framewor 2022-11-09T14:00:01+11:00 https://pharmadispatch.com/news/epiaxis-therapeutics-in-new-agreement-with-us-research-hospital 2022-11-09T14:00:01+11:00 https://pharmadispatch.com/news/ama-sats-government-confirms-no-evidence-for-medicare-fraud-clai 2022-11-09T03:54:01+11:00 https://pharmadispatch.com/news/officials-confirm-pre-budget-submission-to-spending-audit 2022-11-09T16:16:01+11:00 https://pharmadispatch.com/news/vaxxas-launches-clinical-trial-of-needle-free-covid-19-vaccine-c 2022-11-09T20:18:01+11:00 https://pharmadispatch.com/news/minister-officially-launches-plan-for-endometriosis-and-pelvic-p 2022-11-09T20:31:01+11:00 https://pharmadispatch.com/news/hackers-start-posting-customer-data-stolen-from-medibank 2022-11-10T14:00:01+11:00 https://pharmadispatch.com/news/ups-opens-sydney-based-healthcare-distribution-facility 2022-11-10T14:00:01+11:00 https://pharmadispatch.com/news/bupa-welcomes-fair-work-commissions-interim-decision-on-aged-car 2022-11-09T21:38:01+11:00 https://pharmadispatch.com/news/companies-waiting-for-final-outcomes-but-it-may-not-end-next-wee 2022-11-09T23:08:01+11:00 https://pharmadispatch.com/news/shadow-health-minister-makes-a-strong-start-at-senate-estimates 2022-11-11T14:00:01+11:00 https://pharmadispatch.com/news/how-can-more-hta-be-the-solution-to-a-problem-with-hta 2022-11-11T14:00:01+11:00 https://pharmadispatch.com/news/promising-results-from-in-utero-treatment-of-baby-with-pompe-dis 2022-11-11T14:00:01+11:00 https://pharmadispatch.com/news/biomebank-announces-world-first-regulatory-approval-for-donor-de 2022-11-11T04:05:01+11:00 https://pharmadispatch.com/news/brandon-capital-invests-in-neuroscience-company-nrg-therapeutics 2022-11-11T14:00:01+11:00 https://pharmadispatch.com/news/department-confirms-investigation-of-bad-conduct 2022-11-11T07:58:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-11-november 2022-11-12T01:11:01+11:00 https://pharmadispatch.com/news/industry-confirms-the-detail-of-the-new-version-of-horizon-scann 2022-11-14T16:00:01+11:00 https://pharmadispatch.com/news/terms-of-reference-the-first-job-for-hta-review-reference-commit 2022-11-14T14:00:01+11:00 https://pharmadispatch.com/news/the-review-reference-committee-needs-to-manage-this-obvious-conf 2022-11-14T14:00:01+11:00 https://pharmadispatch.com/news/new-south-wales-proposes-dramatic-expansion-of-pharmacy-delivere 2022-11-14T14:00:01+11:00 https://pharmadispatch.com/news/new-insulin-management-system-added-to-ndss-and-prostheses-list 2022-11-14T14:00:01+11:00 https://pharmadispatch.com/news/hcf-life-insurance-products-recognised-with-industry-awards 2022-11-14T01:45:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-more-workers-shifting-towards-healthier-consu 2022-11-14T01:48:01+11:00 https://pharmadispatch.com/news/government-creates-joint-operation-to-target-cyber-criminal-synd 2022-11-14T02:31:01+11:00 https://pharmadispatch.com/news/just-because-the-medicine-is-newly-funded-does-not-make-it-new 2022-11-14T14:00:01+11:00 https://pharmadispatch.com/news/nib-completes-maple-plan-acquisition-and-launches-its-ndis-brand 2022-11-14T23:10:01+11:00 https://pharmadispatch.com/news/positive-trials-results-for-que-oncologys-non-hormonal-oral-ther 2022-11-14T23:20:01+11:00 https://pharmadispatch.com/news/telix-acquires-us-radiochemistry-business-optimal-tracers 2022-11-15T00:06:01+11:00 https://pharmadispatch.com/news/male-contraceptive-implanted-at-epworth-freemasons-in-world-firs 2022-11-15T00:52:01+11:00 https://pharmadispatch.com/news/the-options-will-be-to-accept-delist-or-seek-a-real-political-in 2022-11-15T14:00:01+11:00 https://pharmadispatch.com/news/government-opens-formal-consultation-on-national-newborn-screeni 2022-11-15T14:00:01+11:00 https://pharmadispatch.com/news/global-push-to-raise-awareness-of-biosimilars-as-some-policymake 2022-11-15T03:27:01+11:00 https://pharmadispatch.com/news/this-is-what-happens-when-a-bad-culture-collides-with-capability 2022-11-15T22:12:01+11:00 https://pharmadispatch.com/news/government-adds-pfizers-bivalent-covid-19-vaccine-as-booster-dos 2022-11-16T05:54:01+11:00 https://pharmadispatch.com/news/no-official-should-even-demand-deference-from-a-stakeholder 2022-11-17T14:00:01+11:00 https://pharmadispatch.com/news/csl-launches-consumer-campaign-urging-people-to-see-the-differen 2022-11-17T14:00:01+11:00 https://pharmadispatch.com/news/tga-grants-provisional-determination-for-new-pfizer-bivalent-vac 2022-11-17T14:00:01+11:00 https://pharmadispatch.com/news/cynata-announces-presentation-of-data-demonstrating-consistency- 2022-11-17T02:20:01+11:00 https://pharmadispatch.com/news/new-hope-for-australian-families-carrying-deadly-cancer-gene-var 2022-11-17T02:27:01+11:00 https://pharmadispatch.com/news/medicinal-cannabis-association-announces-the-appointment-of-five 2022-11-17T02:28:01+11:00 https://pharmadispatch.com/news/patients-call-on-all-states-and-territories-to-follow-the-lead-o 2022-11-17T06:14:01+11:00 https://pharmadispatch.com/news/novartis-considers-divesting-ophthalmology-and-respiratory-busin 2022-11-18T14:00:01+11:00 https://pharmadispatch.com/news/this-is-what-happens-with-qum-is-really-just-about-saving-money 2022-11-18T14:00:01+11:00 https://pharmadispatch.com/news/supply-chain-shifts-its-attention-to-managing-catch-up-reduction 2022-11-18T00:37:01+11:00 https://pharmadispatch.com/news/medicines-australia-says-the-push-for-relief-from-price-reductio 2022-11-18T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-18-november 2022-11-18T23:51:01+11:00 https://pharmadispatch.com/news/a-predictable-outcome-that-reveals-deep-scepticism-about-the-val 2022-11-21T14:00:01+11:00 https://pharmadispatch.com/news/ministerial-intervention-in-final-outcomes-as-concern-grows-over 2022-11-21T14:00:01+11:00 https://pharmadispatch.com/news/pbac-advises-against-stand-alone-change-in-base-case-discount-ra 2022-11-21T14:00:01+11:00 https://pharmadispatch.com/news/need-for-more-action-to-ensure-australia-meets-hcv-elimination-g 2022-11-19T14:00:01+11:00 https://pharmadispatch.com/news/mark-butler-launches-new-campaign-to-combat-australias-national- 2022-11-21T01:32:01+11:00 https://pharmadispatch.com/news/medibank-updates-on-cybercrime-and-confirm-the-release-of-new-in 2022-11-21T01:46:01+11:00 https://pharmadispatch.com/news/health-department-one-of-the-first-federal-agencies-to-face-capa 2022-11-22T14:00:01+11:00 https://pharmadispatch.com/news/medtronic-launches-blueballoonchallenge-to-raise-awareness-and-f 2022-11-21T21:57:01+11:00 https://pharmadispatch.com/news/starpharmas-viraleze-launched-in-hong-kong-and-macau 2022-11-21T22:10:01+11:00 https://pharmadispatch.com/news/surely-the-time-has-come-to-stop-pretending-bad-outcomes-are-goo 2022-11-22T14:00:01+11:00 https://pharmadispatch.com/news/australian-launch-for-phase-2-trial-of-new-mrna-vaccine 2022-11-22T04:02:01+11:00 https://pharmadispatch.com/news/the-problem-in-this-system-is-that-the-payer-will-insist-it-is-r 2022-11-23T14:00:01+11:00 https://pharmadispatch.com/news/the-pharmaceutical-sector-will-be-captured-by-new-privacy-penalt 2022-11-23T14:00:01+11:00 https://pharmadispatch.com/news/new-report-finds-australian-cancer-patients-missing-out-on-vital 2022-11-23T14:00:01+11:00 https://pharmadispatch.com/news/csl-secures-us-approval-for-breakthrough-one-time-haemophilia-ge 2022-11-24T14:00:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-two-thirds-of-australians-believe-the-worst-o 2022-11-24T14:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-anticipated-new-therapies-at-its-march-meeting 2022-11-24T14:00:01+11:00 https://pharmadispatch.com/news/industry-partners-to-promote-the-importance-of-regular-heart-hea 2022-11-24T14:00:01+11:00 https://pharmadispatch.com/news/ionopticks-launches-a-new-age-of-proteomics-with-aurora-frontier 2022-11-24T04:06:01+11:00 https://pharmadispatch.com/news/australian-venture-capital-fund-joins-partners-in-backing-new-im 2022-11-24T14:00:01+11:00 https://pharmadispatch.com/news/additional-data-released-from-positive-imaging-trial-in-brain-me 2022-11-24T04:25:01+11:00 https://pharmadispatch.com/news/ninthconsecutive-quarter-of-membership-growth-but-net-profit-dec 2022-11-24T04:33:01+11:00 https://pharmadispatch.com/news/hcf-says-its-long-standing-agreement-with-healthscope-is-likely- 2022-11-24T04:48:01+11:00 https://pharmadispatch.com/news/anniversary-of-parliamentary-inquiry-report-and-still-no-governm 2022-11-25T14:00:01+11:00 https://pharmadispatch.com/news/i-have-said-repeatedly-in-the-last-11-years-that-while-the-pbac- 2022-11-24T22:34:01+11:00 https://pharmadispatch.com/news/committee-recommends-further-changes-to-listing-of-covid-19-anti 2022-11-25T14:00:01+11:00 https://pharmadispatch.com/news/mtaas-ian-burgess-technicians-play-a-vital-role-in-saving-lives 2022-11-25T05:50:01+11:00 https://pharmadispatch.com/news/hcf-says-its-long-standing-agreement-with-healthscope-is-likely- 2022-11-25T05:52:01+11:00 https://pharmadispatch.com/news/the-absence-of-a-government-response-shows-that-it-is-all-about- 2022-11-25T14:00:01+11:00 https://pharmadispatch.com/news/health-department-called-back-for-spillover-estimates-hearing 2022-11-25T14:00:01+11:00 https://pharmadispatch.com/news/the-week-in-review-podcast-25-november 2022-11-25T21:08:01+11:00 https://pharmadispatch.com/news/cepi-reinvests-in-uqs-second-generation-molecular-clamp-vaccine- 2022-11-28T14:00:01+11:00 https://pharmadispatch.com/news/new-study-investigates-the-efficacy-of-apps-for-managing-chronic 2022-11-28T00:19:01+11:00 https://pharmadispatch.com/news/report-reveals-departmental-confusion-over-former-pms-portfolio- 2022-11-28T14:00:01+11:00 https://pharmadispatch.com/news/australian-company-partners-with-queensland-on-major-new-manufac 2022-11-28T14:00:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-new-pbs-listings-for-1-december-1 2022-11-28T02:32:01+11:00 https://pharmadispatch.com/news/uk-observatory-shows-the-way-on-the-future-of-horizon-scanning-1 2022-11-28T14:00:01+11:00 https://pharmadispatch.com/news/report-reveals-departmental-confusion-over-former-pms-portfolio- 2022-11-28T14:00:01+11:00 https://pharmadispatch.com/news/prudential-regulator-intensifies-supervision-of-medibank-in-resp 2022-11-28T21:12:01+11:00 https://pharmadispatch.com/news/inventia-secures-nsw-government-support-to-build-a-new-manufactu 2022-11-28T21:21:01+11:00 https://pharmadispatch.com/news/new-leadership-for-sandoz-australia-and-new-zealand 2022-11-29T14:00:01+11:00 https://pharmadispatch.com/news/emyria-accepted-into-us-national-institutes-of-health-research-p 2022-11-29T00:21:01+11:00 https://pharmadispatch.com/news/bupa-announces-hisham-el-ansary-to-step-down-in-march 2022-11-29T00:36:01+11:00 https://pharmadispatch.com/news/queensland-based-microbio-completes-successful-investment-round 2022-11-29T02:16:01+11:00 https://pharmadispatch.com/news/medicines-australia-welcomes-ministerial-interest-in-catch-up-re 2022-11-29T14:00:01+11:00 https://pharmadispatch.com/news/new-all-female-leadership-team-for-the-australian-private-hospit 2022-11-29T14:00:01+11:00 https://pharmadispatch.com/news/johnson-johnson-head-appointed-new-chair-of-medical-device-secto 2022-11-29T05:00:01+11:00 https://pharmadispatch.com/news/wehi-scientists-recognised-with-csl-florey-medal-for-malaria-res 2022-11-30T14:00:01+11:00 https://pharmadispatch.com/news/sonic-healthcare-takes-a-major-strategic-stake-in-microba-life-s 2022-11-29T22:02:01+11:00 https://pharmadispatch.com/news/will-australia-follow-the-uk-on-missed-diagnosis-and-treatment-d 2022-11-30T14:00:01+11:00 https://pharmadispatch.com/news/adherium-wins-us-fda-clearance-for-use-of-its-digital-platform-w 2022-11-29T22:47:01+11:00 https://pharmadispatch.com/news/immutep-announces-new-collaboration-for-cancer-treatment-combina 2022-11-29T23:36:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-greater-investment-in-arthritis-research 2022-11-29T23:44:01+11:00 https://pharmadispatch.com/news/viatris-managing-director-appointed-to-chp-board-of-directors 2022-11-30T14:00:01+11:00 https://pharmadispatch.com/news/anti-corruption-body-just-months-away-but-what-does-it-mean-for- 2022-12-01T14:00:01+11:00 https://pharmadispatch.com/news/stakeholder-groups-should-intervene-and-make-sure-this-never-hap 2022-12-01T14:00:01+11:00 https://pharmadispatch.com/news/mark-butler-officially-launches-consultation-on-nicotine-vaping- 2022-12-01T14:00:01+11:00 https://pharmadispatch.com/news/first-speakers-confirmed-for-2023-biopharmadispatch-annual-confe 2022-12-01T14:00:01+11:00 https://pharmadispatch.com/news/biogen-eisai-collaboration-delivers-hope-for-alzheimers-disease- 2022-12-01T14:00:01+11:00 https://pharmadispatch.com/news/aged-care-providers-urged-to-prepare-for-staffing-crisis-in-dece 2022-12-01T03:53:01+11:00 https://pharmadispatch.com/news/developer-announces-plans-for-new-medical-research-facility-in-b 2022-12-01T03:55:01+11:00 https://pharmadispatch.com/news/nib-says-survey-shows-why-people-need-to-be-proactive-about-skin 2022-12-01T03:58:01+11:00 https://pharmadispatch.com/news/napwha-and-gilead-recognise-four-community-champions-to-mark-wor 2022-12-01T14:00:01+11:00 https://pharmadispatch.com/news/new-report-confirms-the-dramatic-decline-in-nzs-spending-on-medi 2022-12-02T14:00:01+11:00 https://pharmadispatch.com/news/pandemic-preparedness-the-focus-on-latest-pfizer-invites-event 2022-12-02T14:00:01+11:00 https://pharmadispatch.com/news/committee-skips-pbs-by-cancelling-spillover-hearing-of-senate-es 2022-12-02T14:00:01+11:00 https://pharmadispatch.com/news/private-health-insurers-have-handed-back-21-billion-says-accc 2022-12-02T03:55:01+11:00 https://pharmadispatch.com/news/new-australian-collaboration-to-research-radiopharmaceutical-for 2022-12-02T04:14:01+11:00 https://pharmadispatch.com/news/accc-raises-preliminary-competition-concerns-over-cochlears-acqu 2022-12-02T04:23:01+11:00 https://pharmadispatch.com/news/federal-government-puts-regulatory-changes-before-the-parliament 2022-12-02T14:00:01+11:00 https://pharmadispatch.com/news/federal-agency-launches-investigation-into-medibank 2022-12-02T05:31:01+11:00 https://pharmadispatch.com/news/the-week-in-review-2-december 2022-12-02T22:09:01+11:00 https://pharmadispatch.com/news/sanofi-seeking-support-in-its-campaign-to-encourage-the-return-o 2022-12-05T14:00:01+11:00 https://pharmadispatch.com/news/pfizer-welcomes-expanded-reimbursement-for-lung-cancer-therapy 2022-12-05T14:00:01+11:00 https://pharmadispatch.com/news/committee-to-reconsider-astrazenecas-evusheld-at-upcoming-meetin 2022-12-05T14:00:01+11:00 https://pharmadispatch.com/news/new-zealand-patients-celebrate-provisional-agreement-on-cf-thera 2022-12-05T14:00:01+11:00 https://pharmadispatch.com/news/vaxxas-appoints-doug-cubbin-as-its-new-chief-financial-officer 2022-12-04T22:06:01+11:00 https://pharmadispatch.com/news/gsk-boronia-site-director-on-valuing-the-past-and-finishing-stro 2022-12-05T14:00:01+11:00 https://pharmadispatch.com/news/noxopharm-provides-an-update-on-trial-of-its-oncology-drug-candi 2022-12-04T23:04:01+11:00 https://pharmadispatch.com/news/hbf-and-ramsay-health-care-abolish-co-payment-for-robotic-assist 2022-12-04T23:15:01+11:00 https://pharmadispatch.com/news/bupa-announces-its-new-managing-director-of-health-services 2022-12-04T23:23:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-a-high-level-of-trust-in-member-owned-private 2022-12-05T01:38:01+11:00 https://pharmadispatch.com/news/rt-health-recognised-in-productreviewcomau-annual-awards 2022-12-05T02:01:01+11:00 https://pharmadispatch.com/news/collaboration-with-the-university-of-sa-and-successful-capital-r 2022-12-05T02:51:01+11:00 https://pharmadispatch.com/news/pharmac-hits-a-new-low-with-incompetent-and-childish-response-to 2022-12-06T14:00:01+11:00 https://pharmadispatch.com/news/bms-welcomes-tga-registration-of-first-in-class-tyk2-inhibitor 2022-12-06T14:00:01+11:00 https://pharmadispatch.com/news/sanofi-partners-with-queensland-to-create-the-mrna-translational 2022-12-06T14:00:01+11:00 https://pharmadispatch.com/news/viatris-says-its-stem-workforce-is-critical-to-fulfilling-its-po 2022-12-06T14:00:01+11:00 https://pharmadispatch.com/news/tessara-therapeutics-and-netri-in-new-organ-on-chip-collaboratio 2022-12-06T04:53:01+11:00 https://pharmadispatch.com/news/another-bad-day-for-pharmac-with-ombudsman-to-investigate-docume 2022-12-07T14:00:01+11:00 https://pharmadispatch.com/news/gsks-michelle-strong-on-the-journey-towards-the-end-of-this-chap 2022-12-07T14:00:01+11:00 https://pharmadispatch.com/news/today-fm-and-mediaworks-not-relenting-on-criticism-of-pharmac 2022-12-07T14:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-says-horizon-scanning-needs-purpose-and-an-effector-a 2022-12-07T14:00:01+11:00 https://pharmadispatch.com/news/this-process-needs-clear-direction-from-the-government-or-it-wil 2022-12-07T14:00:01+11:00 https://pharmadispatch.com/news/gsks-michelle-strong-on-the-journey-towards-the-end-of-this-chap 2022-12-07T16:14:01+11:00 https://pharmadispatch.com/news/csl-opens-its-new-australian-plasma-fractionation-facility-in-me 2022-12-08T14:00:01+11:00 https://pharmadispatch.com/news/next-year-will-be-even-tougher-unless-the-downward-trajectory-ca 2022-12-08T14:00:01+11:00 https://pharmadispatch.com/news/construction-is-officially-underway-atmodernas-mrna-site 2022-12-08T14:00:01+11:00 https://pharmadispatch.com/news/ama-says-new-data-reveals-a-worsening-hospital-logjam 2022-12-08T03:55:01+11:00 https://pharmadispatch.com/news/catholic-health-australia-calls-for-reform-of-premium-approval-p 2022-12-08T04:13:01+11:00 https://pharmadispatch.com/news/final-outcomes-add-to-the-evidence-of-the-need-for-a-new-approac 2022-12-08T21:53:01+11:00 https://pharmadispatch.com/news/rachel-smalley-this-is-why-i-say-we-need-to-reform-pharmac 2022-12-09T14:00:01+11:00 https://pharmadispatch.com/news/the-minister-was-never-likely-to-exercise-the-power-but-he-still 2022-12-08T21:41:01+11:00 https://pharmadispatch.com/news/amgen-announces-new-leadership-for-australia-and-new-zealand 2022-12-09T03:14:01+11:00 https://pharmadispatch.com/news/novo-nordisk-named-best-place-to-work-and-best-place-to-work-for 2022-12-09T14:00:01+11:00 https://pharmadispatch.com/news/new-collaborations-takes-steps-to-advance-vaccine-manufacturing- 2022-12-09T04:02:01+11:00 https://pharmadispatch.com/news/medibank-to-undertake-operation-safeguard-at-the-weekend 2022-12-09T04:47:01+11:00 https://pharmadispatch.com/news/the-week-in-review-9-december 2022-12-09T21:37:01+11:00 https://pharmadispatch.com/news/ethics-approval-for-pharmaceuticals-receives-new-diabetic-foot-u 2022-12-11T19:45:01+11:00 https://pharmadispatch.com/news/a-walk-through-time-as-gsk-prepares-to-exit-boronia-production-s 2022-12-12T14:00:01+11:00 https://pharmadispatch.com/news/federal-government-extends-dental-program-for-eligible-children 2022-12-11T20:54:01+11:00 https://pharmadispatch.com/news/probity-has-been-the-early-focus-of-health-technology-assessment 2022-12-11T21:35:01+11:00 https://pharmadispatch.com/news/medibank-says-systems-back-online-after-operation-safeguard 2022-12-11T22:21:01+11:00 https://pharmadispatch.com/news/new-handbook-reveals-a-significant-remaking-of-the-cabinet-proce 2022-12-12T14:00:01+11:00 https://pharmadispatch.com/news/treasury-opens-consultation-process-for-next-years-2023-24-budge 2022-12-12T14:00:01+11:00 https://pharmadispatch.com/news/major-industry-award-for-australian-scientist-at-the-forefront-o 2022-12-13T14:00:01+11:00 https://pharmadispatch.com/news/researchers-infect-a-brain-in-a-dish-in-search-for-zika-antivira 2022-12-12T20:36:01+11:00 https://pharmadispatch.com/news/bupa-reveals-it-top-10-most-common-hospital-and-extras-claims-fo 2022-12-12T20:50:01+11:00 https://pharmadispatch.com/news/avita-medical-ubmits-fda-pma-supplement-to-further-expand-indica 2022-12-12T21:12:01+11:00 https://pharmadispatch.com/news/the-george-institute-sells-george-clinical-and-reinvests-in-its- 2022-12-13T14:00:01+11:00 https://pharmadispatch.com/news/the-era-of-therapy-based-on-gene-editing-is-now-on-the-horizon 2022-12-13T14:00:01+11:00 https://pharmadispatch.com/news/red-havas-makes-new-appointments-to-its-health-and-social-commun 2022-12-13T14:00:01+11:00 https://pharmadispatch.com/news/federal-government-decides-against-extending-pandemic-mental-hea 2022-12-13T01:31:01+11:00 https://pharmadispatch.com/news/vaccination-and-treatment-remain-the-cornerstone-in-updated-covi 2022-12-13T02:11:01+11:00 https://pharmadispatch.com/news/lek-elects-new-managing-partner-and-head-of-australia 2022-12-13T14:00:01+11:00 https://pharmadispatch.com/news/an-appointment-that-is-just-another-sign-of-a-process-in-serious 2022-12-14T14:00:01+11:00 https://pharmadispatch.com/news/amgen-secures-significant-acquisition-of-horizon-therapeutics 2022-12-14T14:00:01+11:00 https://pharmadispatch.com/news/gsk-boronia-and-the-focus-on-finishing-strong-for-patients 2022-12-14T14:00:01+11:00 https://pharmadispatch.com/news/csl-announces-the-appointment-of-its-new-ceo-and-managing-direct 2022-12-14T14:00:01+11:00 https://pharmadispatch.com/news/positive-preliminary-results-from-trial-involving-az-starpharma- 2022-12-14T01:18:01+11:00 https://pharmadispatch.com/news/the-health-department-appears-to-be-confused-about-the-role-of-i 2022-12-14T14:00:01+11:00 https://pharmadispatch.com/news/positive-trial-results-for-combination-of-moderna-mrna-vaccine-a 2022-12-14T16:15:01+11:00 https://pharmadispatch.com/news/ama-says-new-chronic-disease-data-shows-why-government-needs-to- 2022-12-14T20:03:01+11:00 https://pharmadispatch.com/news/medibank-confirms-complaint-lodged-with-the-information-commissi 2022-12-14T20:17:01+11:00 https://pharmadispatch.com/news/two-more-industry-leaders-confirmed-for-bpd-annual-conference 2022-12-15T14:00:01+11:00 https://pharmadispatch.com/news/the-path-is-straightforward-as-long-as-it-is-not-considered-a-va 2022-12-15T14:00:01+11:00 https://pharmadispatch.com/news/if-this-process-requires-a-probity-adviser-what-about-the-others 2022-12-15T14:00:01+11:00 https://pharmadispatch.com/news/moderna-appoints-director-of-regional-research-centre 2022-12-14T23:27:01+11:00 https://pharmadispatch.com/news/under-co-payment-prescriptions-top-100-million-for-the-first-tim 2022-12-15T14:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-appoints-experienced-industry-executive-to-its-board 2022-12-15T02:34:01+11:00 https://pharmadispatch.com/news/mark-butler-announces-new-funding-arrangement-for-surgical-consu 2022-12-15T04:29:01+11:00 https://pharmadispatch.com/news/race-oncology-appoints-new-managing-director-and-ceo 2022-12-15T04:31:01+11:00 https://pharmadispatch.com/news/i-just-think-shes-an-idiot-to-be-perfectly-frank 2022-12-16T14:00:01+11:00 https://pharmadispatch.com/news/it-just-seems-logical-and-reasonable-to-bring-the-two-vaccine-to 2022-12-16T14:00:01+11:00 https://pharmadispatch.com/news/novartis-joins-roche-in-uk-trial-to-extend-access-for-patients-w 2022-12-16T14:00:01+11:00 https://pharmadispatch.com/news/insurer-backs-project-researching-why-patients-dont-response-to- 2022-12-15T23:50:01+11:00 https://pharmadispatch.com/news/pharmac-to-fund-adrenaline-auto-injectors-25-years-after-the-fir 2022-12-16T00:14:01+11:00 https://pharmadispatch.com/news/the-week-in-review-16-december 2022-12-16T21:46:01+11:00 https://pharmadispatch.com/news/peer-reviewed-paper-reveals-enormous-economic-benefit-of-covid-v 2022-12-19T14:00:01+11:00 https://pharmadispatch.com/news/november-outcomes-confounded-by-next-aprils-catch-up-reductions 2022-12-19T14:00:01+11:00 https://pharmadispatch.com/news/pbac-says-a-price-reduction-of-at-least-15-would-be-appropriate 2022-12-19T14:00:01+11:00 https://pharmadispatch.com/news/is-the-system-capable-is-dispensing-with-the-negotiation-by-subm 2022-12-19T14:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-year-in-review 2022-12-20T15:00:01+11:00 https://pharmadispatch.com/news/finalised-nmp-a-significant-improvement-on-the-first-pre-electio 2022-12-20T21:57:01+11:00 https://pharmadispatch.com/news/an-incomplete-list-that-reveals-a-policy-that-fails-one-third-of 2022-12-23T21:47:01+11:00